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Abstract

DIFFUSE BRAIN INJURY TRIGGERS ULTRA-RAPID PERISOMATIC
TRAUMATIC AXONAL INJURY, WALLERIAN CHANGE, AND NON-SPECIFIC
INFLAMMATORY RESPONSES
By Brian Joseph Kelley, Ph.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2006
Major Director: John T. Povlishock, Ph.D.
Professor and Chairman
Department of Anatomy and Neurobiology

A significant component of diffuse brain injury (DBI) is diffuse axonal injury
(DAI) which is responsible for the morbidity and mortality associated with this
condition. DAI and its experimental counterpart traumatic axonal injury (TAI) result in
scattered microscopic pathology characterized by focal impairment of axonal transport
leading to progressive swelling and delayed axotomy. DBI-mediated perisomatic
axotomy does not result in acute neuronal death suggesting that delayed axotomy was
responsible for this unanticipated response. To evaluate this hypothesis, we examined
the spatiotemporal progression of DBI-mediated perisomatic TAI. LM / TEM identified
impaired axonal transport within 15 - 30 min post-injury. Perisomatic TAI revealed

X

somata and related proximal / distal axonal segments with normal ultrastructural detail
continuous with axonal swellings. In other cases, axotomy was confirmed by loss of
axonal continuity distal to the swelling. By 60 - 180 min post-injury, somatic, proximal
segment, and swelling ultrastructure were comparable to earlier time points although
swelling diameter increased. Distal segment ultrastructure revealed the initial stages of
Wallerian degeneration. Axotomy sites did not internalize pre-injury administered
dextran suggesting pathogenesis independent of altered axolemmal permeability. Given
the rapidity of perisomatic axotomy, absence of axolemmal permeability may constitute
the more significant finding in terms of somatic protection.
DBI-mediated neuroinflammatory reactions were then examined to see if this
non-lethal neuronal pathology evoked responses comparable to those following focal
injury. Microglia / macrophage responses within diffusely injured loci uncomplicated
by focal pathology were explored using LM, TEM, and confocal evaluations as was
albumin immunoreactivity to assess injury-induced blood-brain barrier (BBB)
alterations. Initially, microglial activation was observed within injured loci while
microglia within adjoining regions maintained resting phenotypes. Scattered activated
microglia were observed among injured axons though no clear associations were seen.
Later, activated microglia contained myelin debris while only limited microglial
aggregations were recognized. Macrophages also localized to injured loci with select
cells approximating somata of axotomized neurons. Immune cell observations
correlated with altered BBB permeability. These data indicated rapid, yet initially
uncoordinated, and persistent immune cell reactivity to DBI pathology. Taken together,
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these responses suggest that histopathological evaluation following DBI may include
non-lethal neuronal injury with unique neuroinflammatory findings.

Chapter 1

GENERAL INTRODUCTION

TRAUMATIC BRAIN INJURY: SOCIETAL AND ECONOMIC IMPACT
Traumatic brain injury (TBI) is a significant societal problem affecting
approximately 1.4 million individuals each year. While many TBI-related events go
undiagnosed and untreated due to lack of debilitating clinical symptoms associated with
mild head trauma, more moderate to severe injuries account for a significant number of
hospitalizations. Approximately 1.1 million people are treated and released from
emergency departments annually for TBI-related symptoms while 235,000 patients are
hospitalized of which 80,000 - 90,000 cases result in long-term disability and 50,000
cases result in death (Thurman et al., 1999; Langlois et al., 2004). Although these
statistics are lower than those from previous years, the incidence of TBI is still
approximately eight times greater than breast cancer and 34 times higher than
HIVIAIDS causing one report to designate TBI the "invisible epidemic" (Traumatic
Brain Injury 1999; Traumatic Brain Injury 2002). While all age groups are vulnerable to
brain trauma, TBI affects primarily persons aged 0 - 14, 15 - 24 and over 75 (Thurman
et al., 1999). Falls are the leading cause of TBI-related death and disability in children
ages 0 - 14 and elderly people over age 75 while motor vehicle accidents are more
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likely to affect adolescents and young adults ages 15 - 24. It should also be noted that
the very young (ages 0 - 4) have an increased incidence of TBI when compared to the
general population which is presumably a consequence of child abuse (1999). In
addition to age stratification, TBI also demonstrates a gender bias with studies
indicating that across all age categories, men are approximately twice as likely to suffer
from brain injury than women (NIH Consensus Development Panel on Rehabilitation of
Persons With Traumatic Brain Injury, 1999; Langlois et al., 2004).
While data collection and analysis of TBI-related age and gender demographics
is relatively straight forward, it is more difficult to estimate the financial impact of TBI
on society due to the numerous costs associated with evaluation and treatment of the
injured individual as well as economic burdens placed on caregivers. Direct costs of
acute care and rehabilitation for individuals suffering TBI are an estimated 9 - 10
billion dollars annually with a total economic impact of 56.3 billion dollars when
supplementary factors such as long-term care, lost wages, and disability are included
(NIH Consensus Development Panel on Rehabilitation of Persons With Traumatic
Brain Injury, 1999; Thurman, 2001; Traumatic Brain Injury 2002).
A significant component of this estimated total expense is long-term care of the
TBI patient. It is estimated that at least 5.3 million people (approximately 2% of the US
population) are currently living with disabilities or require assistance to perform
activities of daily living as a result of TBI (Thurman et al., 1999). Excluding mortality,
TBI-related clinical outcomes range from return to normal function typically seen
following mild injury to maintenance in a persistent vegetative state following severe
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injury. Individuals sustaining mild TBI generally experience good outcomes with
limited long-term complications although approximately 15 percent will have lingering
problems including headaches, dizziness, attention deficits, and emotional liability
(Alexander, 1995; Guerrero et al., 2000). Similarly, those individuals sustaining
moderate injury may also have positive outcomes although the possibility of permanent
disability or death increases (Levin, 1989). As one might expect, severely brain injured
patients have the worst prognosis and often require full-time medical care when
eventually released from the hospital. In addition to injury severity, age of the
individual sustaining TBI is another important factor with respect to long-term outcome
with older individuals (> 60 years) faring worse than their younger counterparts when
subjected to injuries of comparable severity, presumably due to decreased brain
plasticity (Katz and Alexander, 1994).
With major economic burdens coming from both acute and long-term care
expenses, education and prevention remain at the clinical forefront in reducing the
incidence of TBI. Ongoing efforts to increase head injury protection awareness, to
prevent falls, and to improve vehicle safety have made strides in reducing the number of
severely head-injured people. Similarly, improved clinical management of hospitalized
TBI patients has also improved long-term outcomes. Efforts to reduce TBI morbidity
and mortality are also ongoing in the basic science realm through research into the
underlying cellular and molecular pathobiology associated with this condition. Study of
the intricate post-injury responses and interactions between various brain cell types and
molecules remain active areas of investigation. As a more complete understanding of
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the pathophysiological processes involved in TBI emerges, the importance of bench-tobedside translational research will be highlighted, especially in areas such as therapeutic
interventions targeting specific pathological events.
While basic science research has advanced our understanding of TBI
pathobiology, there remain many unanswered questions regarding the various
mechanisms responsible for this "invisible epidemic." In that society's goal is to one
day be able to intervene and prevent the devastating consequences of this debilitating
condition, this dissertation was developed to provide additional insight into two major
components of TBI pathogenesis. First, the spatiotemporal progression of a key
component of diffuse TBI namely diffuse axonal injury (DAI), as known as traumatic
axonal injury (TAI) in experimental settings, was evaluated in the perisomatic domain
using a fluid percussion injury model of diffuse brain injury (DBI). Second, the
neuroinflammatory responses accompanying DBI and its associated pathology were
explored. To outline this dissertation, a general introduction to TBI and its components
is first provided to give background on this pathology. This is followed by individual
chapters devoted to perisomatic TAI pathogenesis (Chapter 2) and microglial /
macrophages responses to DBI (Chapter 3). A general discussion (Chapter 4) is then
offered to provide additional insight into these observations and to suggest future
studies aimed at developing a more comprehensive understanding of these events.
Ultimately, as our understanding of the underlying pathophysiology of TBI continues to
improve, we must translate our basic science findings to the clinical arena with the hope
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of offering concomitant improvements in medical care and long-term outcomes for TBI
patients.

TRAUMATIC BRAIN INJURY: GENERAL OVERVIEW
The term "TBI" is used to describe a wide variety of clinical conditions ranging
from concussion following closed head injury to missile injury from a gunshot wound.
Although both are considered to be "TBI," their respective mechanisms of injury and
consequent pathologies differ significantly. Recent basic science characterization has
divided TBI into four phases of pathogenesis: the primary injury, the delayed
consequences of the primary injury, secondary or additional injury, and recovery and
functional outcome (Graham et al., 2002) with each of these stages affected by
numerous factors. For example, the primary injury is dictated by the type, location, and
size of injury produced by the causative agent while secondary injury is influenced by
co-morbidities associated with brain trauma such as elevated intracranial pressure and
ionic dysregulation. While the above characterization offers a synopsis of general TBIrelated pathologies, a more descriptive classification outlined below utilizes injury
location.
To begin to describe the pathogenesis of brain trauma, TBI may be first
stratified into two major categories: focal and diffuse injury. This distinction is not
arbitrary given that the need for surgical evaluation in focal injury is much greater than
in diffuse injury (Graham et al., 2002). Focal brain injury, which most often occurs as a
result of direct impact of the brain against the cranial vault, is characterized primarily
by contusions, hemorrhages 1 hematomas, andlor mass lesions. These outcomes are in
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contrast to the effects of diffuse injury that typically occur via rapid acceleration deceleration of the cranium with or without impact resulting in shear forces distributed
throughout the brain parenchyma (Graham, 1996). While focal injury is often visible
either grossly or with clinical imaging techniques, diffuse pathology is more subtle
given the injury dynamics and distribution. Diffuse brain pathology is microscopic in
nature and involves cellular changes scattered throughout various anatomical loci. It is
often difficult to detect using conventional imaging and therefore the diagnosis of DBI
is often based on neurological deficits found during clinical examination or via postmortem histological examination of specimens stained with antibody markers of
neuronal injury. Although focal and diffuse injury may appear to be unique entities,
they are often found within a single brain (Finnie et al., 2002). This observation
highlights the complexity of TI31 and illustrates the difficulty of studying either focal or
diffuse pathology in isolation.

Focal versus Diffuse Injury
As noted, TBI may be classified as either focal or diffuse depending on the type
and size of injury as well as brain localization. Focal damage includes pathologies such
as contusion and/or laceration to the brain surface, intracranial hematoma, hemorrhage
and infarction in the brainstem, and abscess formation (Graham et al., 2002).
Distinguishing characteristics of focal brain injury include similar fates for related cell
types within an injury nidus and diminishing pathological severity as the distance away
from the nidus increases. For example, following a severe focal brain contusion, the
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ensuing pathology consists of rapidly necrotic cell death creating a necrotic central core
which is surrounded by a penumbral region of heterogeneously injured cells which may
die via delayed apoptosis (Clark et al., 1999), thus expanding the core region. Within or
immediately adjacent to the penumbra, cells may be only transiently affected and
survive to recover normal function (Adams, 1992). Ultimately, this transiently affected
area is encircled by uninjured tissue giving the overall injury location a concentric
circular appearance in terms of cellular injury severity, with more severe injury at the
center and little to no injury at the margins.
The focal injury force is concentrated on a local area and typically results in
immediate physical damage to cells. If sufficient magnitude is applied, cells will
experience direct mechanical injury to their membranes leading to loss of ionic
homeostasis. Ionic dysregulation leads to loss of energy substrate production and
various intracellular pathologies ultimately culminating in necrotic cell death. Those
cells immediately adjacent to the central impact location experience varying degrees of
force resulting in variety of pathological outcomes. Thus force magnitude is responsible
for the size over which the focal injury extends into the brain parenchyma. From the
standpoint of diagnosis and treatment, the location of focal injury may be determined
based on neurological deficits observed during clinical examination andlor imaging
techniques, depending on the patient's level of consciousness.
Conversely, diffuse injury exists in primarily four forms: diffuse axonal injury,
diffuse hypoxic brain damage, diffuse brain swelling, and diffuse vascular injury.
Diffuse injury results from dynamic loading via impact or impulsive forces with strain
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being the proximate cause of brain tissue injury. The types of strain responsible for
pathology include primarily tension and shear (Graham et al., 2002). When these strain
forces exceed certain viscoelastic property thresholds for neurons andlor other cell types
within the brain, damage to cell membranes and fibers occurs resulting in altered
permeability and possible mechanical tearing. Although strain forces during injury may
result in immediate tearing of cell membranes, forces causing transient membrane
perturbation without mechanical rupture may also initiate of a number of pathological
cascades resulting in delayed pathology.
During trauma, strain forces are distributed throughout the brain with varying
degrees of severity exposing cells to unequal levels of perturbation (Margulies and
Thibault, 1989; Margulies et al., 1990). For example, experimental studies have
determined that the gray-white matter interface is selectively vulnerable to shear forces,
presumably due to the differing densities of the two areas, resulting in axonal damage
following rapid acceleration and deceleration (Meaney et al., 1995; Smith et al., 1997).
While certain axons may be exposed to forces sufficient to cause injury, other
neighboring fibers may not be damaged despite experiencing similar albeit unequal
forces. This phenomenon results in heterogeneous injury of a diffuse nature. Therefore,
unlike focal TBI, the extent of diffuse injury is more difficult to diagnose and treat due
to more variable areas of the brain being affected as well as the microscopic nature of
injury which makes diagnostic imaging difficult.
Ultimately, focal and diffuse injury may be thought of as ends of a continuum
between which TBI-related conditions fall. Although focal and diffuse brain injury can

occur in isolation, in many cases aspects of both injuries can be found within an
individual brain. One might envision a scenario (e.g. motor vehicle accident) during
which the brain may experience supra-threshold tension and shear strains due to rapid
deceleration causing altered membrane permeability and mechanical tearing followed
by impact with the cranial vault causing a contusion. Therefore, in order to discern the
various pathological mechanisms following focal and diffuse TBI, one must attempt to
study either focal or diffuse injury in isolation with the understanding that these
complex pathologies often overlap within an individual traumatically injured brain.

DIFFUSE / TRAUMATIC AXONAL INJURY: GENERAL INTRODUCTION
Although there are four primary forms of diffuse TBI, diffuse axonal injury
(DAI) has received the most attention due to its association with poor prognoses
following injury (Graham, 1996). As noted, the ability to diagnose DBI is hampered by
the microscopic nature of injury. Conventional imaging techniques may offer signatures
of DAI but lack the resolution to examine individual axons and determine their health
following trauma. Often times, a final clinical diagnosis of DAI is reached by default
after ruling out other possible pathologies. For example, a physical examination (e.g. an
unresponsive comatose patient) that is incongruent with diagnostic radiographic
findings (e.g. various imaging scans fail to show significant brain pathology) is often
diagnostic for severe DAI. The histological pathology of DAI is characterized by
widespread axonal damage in the brainstem, parasagittal white matter of the cerebral
cortex, and corpus callosum and is a consistent feature of TBI (Adams et al., 1989;

Meythaler et al., 2001). To provide a more thorough understanding of DAI, the
following sections first discuss the historical and current clinical perspectives. This is
followed by a descriptive characterization of traumatic axonal injury (TAI), the
experimental counterpart of DAI, and the molecular processes responsible for its
pathogenesis.

Diffuse Axonal Injury: Historical Perspective
The first microscopic identification of DAI was made in 1956 when Sabina
Strich examined five severely disabled individuals surviving for between five and 15
months following TBI (Strich, 1956). During post-mortem examination of brain
specimens, Strich observed "diffuse degeneration" of cerebral hemisphere white matter.
Otherwise, minor pathological changes were noted that were inconsistent with the
overall severity of injury demonstrated during clinical examination prior to autopsy.
Although the mechanical force of injury was suggested as a contributing factor, it was
not until a follow-up study five years later that Strich identified 15 additional patients
with similar pathologic findings and concluded that there was immediate shearing of
nerve fibers at the time of injury and that this pathology was marked by the presence of
"retraction balls" at the ends of these interrupted fibers (Strich, 1961). Strich discussed
the implications of head movement in a variety of rotational and angular planes and
concluded that ". .. nerve fibers running in a particular direction would be selectively
damaged in one hemisphere and spared in the other, the quantity of damage being the
same on the two sides" (Strich, 1961). Although her initial assessment of axonal injury
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pathogenesis was partially flawed, Strich's pioneering work laid the foundation for
more comprehensive analyses of axonal damage following TBI.
Comprehensive examinations into the mechanisms of axonal injury and
disconnection began in the late 1970's and early 1980's with the development of TBI
animal models capable of reproducing axonal injury (Sullivan et al., 1976; Gennarelli et
a]., 1982). Although not initially intended to examine axonal pathology, Sullivan and
colleagues developed a feline model in which a swinging weight would strike a piston
connected to a saline filled reservoir which, in turn, was connected to the epidural space
of the animal (Sullivan et al., 1976). This fluid percussion injury device produced an
elastic deformation in the brain similar to that seen in human head injury. However, it
was not until several years later that Povlishock and colleagues first reported the diffuse
axonal pathology generated by this model (Povlishock et al., 1983). One year prior to
the observations made by Povlishock, Gennarelli and colleagues developed the first
model capable of eliciting symptoms and axonal pathology consistent with that
observed in severe human head injury (Gennarelli et al., 1982). Using a primate model,
animals were subjected to sagittal, oblique, and lateral head motion with select animals
experiencing post-injury coma in the absence of overt pathological change. Similarly,
there was microscopic evidence of diffuse axonal swelling and disconnection,
observations similar to those made by Strich. Gennarelli, as well as Adams whose
article appeared in the same journal, termed this phenomenon "diffuse axonal injury" or
DAI (Adams et al., 1982; Gennarelli et al., 1982).
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As mentioned, the first study characterizing the axonal response to TBI-induced
DAI was performed by Povlishock and colleagues (Povlishock et al., 1983). In this
work, horseradish peroxidase (HRP) was injected into the motor cortex prior to fluid
percussion injury. Capitalizing on the fact that HPR would be taken up by neurons and
subsequently undergo anterograde transport down the axonal cylinder, this study was
designed to show the spillage of HRP into the surrounding brain parenchyma
immediately following TBI-induced axotomy based on Strich's hypothesis that axonal
retraction balls were formed by extrusion of axonal contents at the injury site (Strich,
1961). However, this observation was not seen. Rather, focal HRP accumulations were
observed within continuous axons at early post-injury time points. At later times, these
HRP-laden swellings enlarged and eventually lost continuity and disconnected from
their downstream segments while restricting HRP to the intra-axonal compartment
(Povlishock et al., 1983). These novel observations led to the following conclusions:
First, not all fibers undergo immediate axotomy post-injury and second, that during this
process of delayed axotomy, axonal injury appears to take place without permanent loss
of membrane integrity.
These initial observations provided the framework for future experiments
designed to examine DAI pathobiology. Research into the spatiotemporal progression
and mechanisms of DAI has provided unique insights into the development of TBIinduced axonal injury. As will be discussed in subsequent sections, our clinical and
basic science comprehension of DAI over the last 30 years has grown tremendously in
its breadth and sophistication.

Diffuse Axonal Injury: Clinical Perspective
The predominant pathological mechanism in most cases of TBI is DAI (Bennett
et al., 1995). However, given the diffuse and microscopic nature of injury, many TBI
patients with underlying DAI will have minimal changes noted on computed
tomography (CT) and magnetic resonance imaging (MRI) scans during clinical
evaluation (Bazarian et al., 2006). One prognostic indicator of DAI that may be seen on
imaging are punctate hemorrhages that are associated with blood that extravasates from
small vessels and that occur in areas of the brain contiguous with DAI (Meythaler et al.,
2001). Shear forces responsible for axonal damage are also believed to create small
tears in the vasculature causing small focal hemorrhages that enhance when imaged.
These imaging findings along with clinical diagnoses of coma and/or low Glasgow
Coma Score (e.g. GCS < 8) are strongly diagnostic for severe DAI. Mild to moderate
DAI diagnoses rely primarily on neurological and/or cognitive deficits found during
more routine clinical examination.
To provide clinical classification for DAI severity, Adams and colleagues
developed a grading system based on post-mortem brain distribution of axonal
pathology (Adams et al., 1977; Adams et al., 1989; Adams, 1992). In this classification,
mild or grade 1 DAI is characterized by microscopic changes in the white matter of the
cerebral cortex, corpus callosum, brainstem, and occasionally the cerebellum. Moderate
(grade 2) DAI is defined by grossly evident focal lesions isolated to the corpus
callosum. In severe (grade 3) DAI, there are additional focal lesions in the dorsolateral
quadrants of the rostra1 brainstem, commonly the superior cerebellar peduncle.

14
Although the basis for this classification scheme is limited to post-mortem analyses,
evidence of punctate hemorrhages found on imaging studies and located at the above
mentioned anatomic loci may offer diagnostic insight into injury severity.
Improved scientific understanding of DAI pathogenesis has provided
opportunities to develop treatment strategies aimed at prevention / attenuation of axonal
pathology following TBI. From work in animal models, pathological characteristics
such as delayed axonal swelling and disconnection have been elucidated. Given this
delayed axotomy component, DAI offers a unique "therapeutic window" during which
pharmacological andlor physiological manipulations may be employed to improve
patient outcome. Although advancements in clinical intensive care management have
improved patient outcomes, concomitant therapeutic treatment options have not been as
forthcoming. Several pharmaceutical agents showing promise in animal studies have
not achieved similar success when carried over to the clinical realm (Narayan et al.,
2002). Similarly, attempts to slow TBI-induced pathological cascades by cooling
patients to a hypothermic state followed by rewarming remains experimental and thus,
controversial (Clifton et al., 2001; Markgraf et al., 2001). The inability of a single
therapeutic intervention to fully attenuate DAI highlights the multiple pathological
processes at work following trauma. These processes are the focus of the next section.

Traumatic Axonal Injury - Initiating Events
A point of clarification concerning nomenclature is necessary prior to a
descriptive characterization of DAI pathobiology. The term "diffuse axonal injury" is
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used to describe the human clinical condition associated with brain trauma. Given the
importance of animal modeling to DAI hypothesis testing and the related difficulty in
translating experimental results to the human condition, different terminology is used
when discussing DAI within the context of basic science research. Rather, "traumatic
axonal injury" (TAI) is reserved for pathology found in animal models of TBI and may
refer to diffuse injury or injury within a single axon. Thus, "TAI" is used throughout
this section to denote axonal injury within the context of experimental diffuse TBI.
Similar to the continuum of potential clinical conditions created by focal and
diffuse injury, TAI also demonstrates a continuum of pathological change. TAI as a
consequence of DBI may range from immediate tearing of the axonal membrane
following trauma to fibers that experience shear and tensile strain forces but are not
immediately severed. At one end of the continuum are strain forces sufficient to tear
axons immediately following trauma resulting in what is known as "primary axotomy"
or disruptive axonal injury (Maxwell et al., 1997). The remaining forces are of
intermediate severity which do not cause immediate tearing but are responsible for
initiating pathological mechanisms resulting in delayed 1 "secondary axotomy" or nondisruptive axonal injury during which axonal disconnection takes place at some point
following the initial insult.
Historically, two hypotheses attempted to explain the biochemical and
biophysical mechanisms occurring within axons that initiate secondary axotomy
(Fitzpatrick et al., 1998). Although both implicated the axolemma as the initial site from
which traumatically induced axonal pathology persists, they differed in their mechanism
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of action. Adams and colleagues along with others proposed that focal perturbation of
the axolemma was the crucial initiating event (Adams et al., 1982; Gennarelli et al.,
1982; Adams et al., 1989; Maxwell et al., 1991). This perturbation was associated with
increased permeability of the axolemma causing loss of ionic homeostasis across the
axonal membrane and allowing for influx of extracellular calcium. Increased intraaxonal calcium, in turn, stimulated activation of proteolytic enzymes that caused
collapse and dissolution of the axonal cytoskeleton, which disrupted axonal transport
leading to organelle accumulation, axonal swelling, and progression towards secondary
axotomy. On the other hand, Povlishock and colleagues proposed that the physical
forces of injury directly perturbed the intra-axonal ultrastructure leading to altered
cytoskeletal alignment and consequent impaired axonal transport (Povlishock, 1992;
Grady et al., 1993; Christman et al., 1994).
More recent work by the Povlishock group has demonstrated that the initiating
events in TAI pathogenesis are heterogeneous and complex processes thought to
involve multiple and varied pathologies including the possibility of altered axolemmal
permeability. To explore potential alterations in axolemmal permeability, the use of
extracellular tracers, namely horseradish peroxidase (HRP; MW = 44 kDa) and high
molecular weight dextrans (MW = 10 & 40 kDa) normally excluded from intact axons,
was employed in separate animal models of DBI. The rationale for these studies was to
show that if axonal perturbation led to altered permeability, then these extracellular
tracers would enter the axon thus marking not only axonal injury but also sites of focal
perturbation. Pettus and colleagues first explored this concept by flooding the extra-
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axonal space within the brainstem with HRP and then demonstrated HRP movement
into the intra-axonal space immediately following moderate but not mild TBI (Pettus et
al., 1994). Subsequent work confirmed these observations and given the lack of specific
neuronal HRP uptake, were interpreted to mean that physical injury caused a focal
membrane opening (i.e. mechanoporation) allowing for HRP influx (Pettus and
Povlishock, 1996). Similar work using high molecular weight dextrans
intracerebroventricularly infused prior to injury to evaluate somatic permeability

following DBI revealed multiple independent neuronal injury phenotypes including
evidence suggesting both permeabilized and non-permeabilized axons (Singleton and
Povlishock, 2004). Finally, in work presented in the next chapter, data showed that
thalamic perisomatic axonal injury occurred independently of overt alterations in axonal
permeability based on exclusion of pre-injury administered dextrans from injured
axons. Collectively, these observations highlight the heterogeneity of initial axolemmal
involvement in TAI pathogenesis.
In addition to the Povlishock group, other groups have also explored initiating
mechanisms of axonal injury following DBI. Using a related in vitro stretch injury
model which mimics the tensile loading incurred by axons during diffuse injury, Wolf
and colleagues identified ion channels as a causative agent. Using ion sensitive dyes in
combination with channel blockers, stretch injury did not cause mechanoporation
allowing for passage of extracellular tracers into the intra-axonal space of cultured
neurites. Instead, aberrant sodium channel opening was observed leading to
depolarization and increased intra-axonal sodium concentrations. These elevated
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sodium levels caused opening of voltage-gated calcium channels and reverse operation
of the sodium-calcium exchanger, both of which led to increased intra-axonal calcium
levels (Wolf et al., 2001). In addition to these observations, similar work by Smith and
colleagues also illustrated axonal injury in the absence of dye uptake following stretch
injury (Smith et al., 1999). More recent in vivo work by Stone and colleagues suggested
that altered axolemmal permeability occurs only within a subset of uniquely injured
axonal fibers following TBI (Stone et al., 2004).
Despite the heterogeneity surrounding the role of axolemmal perturbation as the
causative agent for TAI, the unregulated entry of calcium into the axon following
trauma is undoubtedly responsible for proteolytic cascade activation leading to
cytoskeletal pathology. Calcium has been identified as a key mediator in a variety of
neuronal pathological pathways (Young, 1996). Within the context of TAI, calcium has
been identified at sites of focal injury (Maxwell et al., 1995) and has been shown to
stimulate a number of proteolytic enzymes which target the axonal cytoskeleton leading
to altered ultrastructural morphology (Buki et al., 1999; Buki et al., 2000). Focal
cytoskeletal alterations in neurofilament, microtubule, and subaxolemmal spectrin
ultrastructure lead to impairment of axonal transport at these sites. Despite axonal
injury, continued anterograde transport from the soma results in organelle pooling at the
site of impaired transport which causes focal axonal swelling. Axonal swelling may
progresses over time ultimately leading to axotomy and disconnection although a recent
study from the Povlishock group indicates that neurofilament compaction, occurring
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independently of impaired axonal transport, may also be responsible for TAI pathology
(Marmarou et al., 2005).

Markers of Traumatic Axonal Injury
TAI is marked by impaired axonal transport and altered cytoskeletal
ultrastructure. It would therefore seem reasonable and rational to exploit these
characteristics when trying to identify traumatically injured axons following DBI.
However, in studies first identifying TAI, Strich utilized silver impregnation methods to
identify swollen axons (Strich, 1956; Strich, 1961). Although the mechanism by which
injured axons are marked with silver labeling remains poorly understood and is thought
to underestimate the total number of injured fibers (Gentleman et al., 1995), this
methodology is still used to identify axonal injury, primarily in white matter tracts
(Hicks et al., 1996; Adelson et al., 2001; Ding et al., 2001; Gallyas et al., 2002; Hall et
al., 2005a; Hall et al., 2005b). A second and better understood marker of TAI first
utilized by Povlishock and colleagues is horseradish peroxidase (HRP). Following
somatic uptake via endocytosis, HRP-laden vesicles move via fast anterograde axonal
transport and pool at sites of axonal injury marked by impairment of axonal transport.
With axonal injury and subsequent impairment of axonal transport being focal events,
continued delivery of anterogradely transported molecules, such as HRP, lead to
progressive swelling and immunoreactivity in initially continuous but later disconnected
reactive axonal swellings (Povlishock et al., 1983). HRP was later found to have the
added advantage of marking sites of traumatically-induced alterations in axolemmal

permeability via pre-injury lateral ventricle infusion and subsequent dispersion
throughout the extracellular brain parenchyma (Pettus et al., 1994). More recently,
antibodies to specific neurofilament subunits have been useful in marking altered
cytoskeletal morphology at sites of axonal injury (Grady et al., 1993; Maxwell and
Graham, 1997; Povlishock et al., 1997).
However, the current standard for detection of axonal injury following traumatic
insult is visualization of P-amyloid precursor protein (APP). APP was first utilized as a
marker for axonal injury by Gentleman and colleagues (Gentleman et al., 1993) after an
earlier study by Shigematsu and McGeer revealed swollen APP positive axons, similar
to those seen following trauma, within the periventricular white matter following the
application of the microtubule stabilizing agent colchicine (Shigematsu and McGeer,
1992). APP is an integral membrane protein that undergoes vesicular-mediated fast
anterograde axonal transport. Similar to the mechanism by which HRP marks sites of
axonal injury, APP moves along the axon until reaching a site of focally impaired
transport at which point the site of axonal injury will undergo expansion due to the
continued delivery of transported organelles. Focal APP accumulation at the site of
impaired axonal transport will lead to increased immunoreactivity of the injury focus as
well as the related proximal axonal segment and corresponding soma. Visualization via
routine antibody processing (Stone et al., 2000) allows for identification of axonal
injury within white matter tracts as well as at perisomatic locations. The ~ltilityof APP
antibody immunoreactivity as a specific marker for axonal injury has gained wide
acceptance in studies of both basic science and forensic pathology (Blumbergs et al.,
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1994; McKenzie et al., 1994; Sherriff et al., 1994a; Sherriff et al., 1994b; Blumbergs et
al., 1995; Gentleman et al., 1995; Lewen et al., 1995; Li et al., 1995; Ahlgren et al.,
1996; Lewis et al., 1996; McKenzie et al., 1996; Pierce et al., 1996; Abou-Hamden et
al., 1997; Bramlett et al., 1997; Geddes et al., 1997; Murakami et al., 1998; Oehmichen
et al., 1998; Van den Heuvel C. et al., 1998; Gleckman et al., 1999; Stone et al., 1999;
Finnie et al., 2000; Masumura et al., 2000; Stone et al., 2000; Singleton et al., 2002).

Traumatic Axonal Injury - Cytoskeleton and Related Pathology
While altered axolemmal permeability and elevated intra-axonal calcium are the
initiators of TAI pathogenesis, the resultant cytoskeletal pathology is responsible for the
morphological change observed in injured axons following DBI. Therefore, in order to
outline TAI pathogenesis, background information on axonal cytoskeletal composition
is first provided. This information provides a conceptual framework on which
mechanisms of TAI-related cytoskeletal pathology are discussed.
There are three distinct interacting structural proteins that comprise the neuronal
cytoskeleton: microtubules (MTs), neurofilaments (NFs), and microfilaments (MFs)
(Siege1 et al., 1999). Together, these proteins form the dynamic structural latticework,
encompassed by the axolemma, which serves as a scaffold for neuronal
cytoarchitecture. Neurons are a highly polarized cell type that must transduce signals
from one end of the cell to the other and thus, are highly dependent on their structural
integrity to maintain their function. This polarization results in an axonal cytoskeletal
composition that is distinct from that found in the somatic and dendritic compartments.
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The axonal cytoskeleton is characterized by MTs arranged in small clusters along with
dense arrays of NFs and a subaxolemmal network of MFs. Axonal MTs have uniform
orientation (Kirkpatrick and Brady, 1999) which has implications for intracellular
trafficking of membrane-bound organelles via molecular motor proteins (Brady, 199 1;
Vallee and Bloom, 1991). Similarly, NFs are oriented longitudinally, parallel to each
other, and are inter-connected (Hirokawa, 1991). Interestingly, the composition of
cytoskeletal elements within the axon dictates axonal caliber and thus controls the speed
of impulse propagation (Pijak et al., 1996; Elder et al., 1998). This section offers a
detailed description of each cytoskeletal protein along with their respective roles in
axonal cytoarchitecture, intracellular transport, and TAI-related pathology.

Axonal Cytoskeleton

Microtubules (MTs) consist of polymers of globular tubulin subunits arranged in
a cylindrical tube measuring 24 nm in diameter. Each tubulin dimer consists of two
closely related polypeptides, a and P-tubulin (Schwartz and Westbrook, 2000). Head-totail arrays of tubulin heterodimers give protofilaments of which 13 are arranged in a
tubular array around a hollow core. Tubulin heterodimer orientation imparts polarity to
the MT, creating plus (fast-growing) and minus (slow-growing) ends. As noted, this
polarity has intra-neuronal regional specificity with axonal MTs having minus ends
oriented towards the cell body and plus ends oriented towards the nerve terminal
(Heidemann SR et al., 1985). Although exhibiting "dynamic instability" during which
they oscillate between growth and shortening phases (Mitchison and Kirschner, 1984),

23
neuronal MTs are relatively stable structures due to post-translational modification of
tubulin following incorporation into the MT framework and alteration of intrinsic MT
properties via binding by a class of molecules known as microtubule-associated proteins
(MAPs). There are several MAPs, each of which demonstrates regional specificity, with
tau being unique to axonal cytoarchitecture (Vallee et al., 1984).
In addition to structural support, MTs function as a "highway" for bidirectional
organelle transport (Goldstein and Yang, 2000) to exchange structural and functional
materials within the neuron. Organelle movement within the axon is either away from
the soma (anterograde) or towards the soma (retrograde) (Lodish et al., 1999). This
directed movement may be exploited to identify loci of axonal injury following trauma
via use of antibodies targeting anterogradely transported proteins. These proteins collect
at sites of impaired axonal transport thus identifying sites of axonal injury.
Neurofilaments (NFs) are stable polymers of neuron-specific intermediate
filaments that do not demonstrate the dynamic properties of MTs (Schwartz and
Westbrook, 2000). Grouped as "intermediate" because their diameter (10 nm) is
between that of MTs and MFs (discussed shortly), NFs are assembled into rope-like
filaments that twist around each other to produce coils of increasing thickness.
Monomers form heterodimers which aggregate into tetrameric complexes known as
protofilaments. Two protofilaments join to become a protofibril and three protofibrils
twist helically to form the NF (Bershadsky and Vasiliev, 1988). In contrast to MTs and
MFs which contain globular proteins and have polarity, NF monomers are highly
elongated apolar fibrous proteins when assembled (Cooper, 2000). There are three
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primary NF polypeptides: NF-light (NF-L), NF-medium (NF-M), and NF-heavy (NF-

H), which differ in molecular weight (60-70, 130-170, and 180-200 kDa respectively).
Polymer formation requires the NF-L subunit together with either the NF-M or NF-H
subunit (Julien and Mushynski, 1998). Once assembled, NFs are transported to their site
of incorporation into the cytoskeletal network (Nixon et al., 1989). During transport, all
three NF subunits undergo a complex pattern of phosphorylation and dephosphorylation
which regulates the different assembly states of the protein before and during axonal
transport (Sihag and Nixon, 1989; Sihag and Nixon, 1990).
NFs differ from other intermediate filaments by their sidearms that project from
the surface and cause them to be widely spaced (Lee and Cleveland, 1996; Kirkpatrick
and Brady, 1999). Sidearms are the carboxy-terminal regions of the NF-M and NF-H
polypeptides and contain a large number of consensus phosphorylation sites (KSP {LysSer-Pro } sequence repeats) targeted by various kinases (Shaw, 1991; Julien and
Mushynski, 1998). Sidearm phosphorylation alters the charge density on the NF
surface, repelling adjacent NFs with similar charge (Gotow et al., 1994) and is a major
determinant of axonal diameter (Brady, 1993). Sidearms are also thought to play a
structural support role through binding to MTs (Lodish et al., 1999).
Microfilaments (MFs) are dynamic components of the membrane cytoskeleton,
the area immediately adjacent to the plasma membrane (Hitt and Luna, 1994; Beck and
Nelson, 1996). MFs are formed from globular actin monomers (G-actin) arranged like
two strings of pearls intertwined into fibrils 4-6 nm in diameter (Kirkpatrick and Brady,
1999). Each actin monomer has binding sites that mediate head-to-tail interactions with

two other actin monomers to mediate polymerization (Cooper, 2000). The filamentous
polymer (F-actin) is uniformly oriented and demonstrates polarity. MFs are organized
into a meshwork of short oligomers near the axolemma and axonal MTs (Kirkpatrick
and Brady, 1999).
In addition to actin MFs, several MF-associated proteins have been described
(Vandekerckhove and Vancompernolle, 1992). These proteins provide further structural
support to the membrane cytoskeleton via actin binding. One protein relevant to TAI
pathology is spectrin. Spectrin is a flexible, rod-shaped molecule composed of
homologous a and P subunits originally characterized in the erythrocyte membrane
cytoskeleton. Spectrin heterodimers align to form tetramers which are cross-linked by
short actin MFs (Kirkpatrick and Brady, 1999). This spectrin-actin network is coupled
to the plasma membrane through direct binding to membrane proteins and serves to
stabilize the membrane.

Cytoskeletal Pathology

To determine axonal cytoskeletal alterations at the injury site, the injured area
must be first identified and visualized. TAI is associated with focally impaired axonal
transport and concomitant axonal swelling. Capitalizing on the fact that post-injury
axonal transport remains functional but is focally disrupted, immunohistochemistry with
antibodies to P-APP, a molecule which moves via vesicular-mediated anterograde
transport, is used to target the site of impaired axonal transport. APP and other
intracellular organelles are anterogradely transported to a site at which they can
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progress no further. The continued delivery and accumulation of APP and organelles at
this site results in focal axonal swelling. APP may be visualized using routine light
microscopy followed by tissue processing for electron microscopy to examine axonal
ultrastructure.
Previous studies of TAI pathology have demonstrated cytoskeletal disruption at
focal axonal swellings. In long tract axons of the brainstem, Pettus and Povlishock first
noted NF misalignment and alterations in axolemmal permeability associated with rapid
local NF compaction following moderate TBI, leading to delayed progression of
reactive axonal change (Pettus et al., 1994). A subsequent study provided more
complete cytoskeletal characterization including decreased inter-NF spacing associated
with loss of sidearm projections, as well as increased NF packing and decreased MT
density following moderate TBI (Pettus and Povlishock, 1996). These changes were
hypothesized to cause focal impairment of axonal transport due to local ionic
dysregulation given the passage of HRP into damaged fibers. Similar work by Maxwell
and Graham showed focal reactive axonal change with loss of axonal MTs and NFs
following non-disruptive optic nerve stretch injury (Maxwell and Graham, 1997) as did
comprehensive morphological quantification studies by Jafari and colleagues (Jafari et
al., 1997; Jafari et al., 1998). Further studies examining long tract axonal NF sidearms
following TBI demonstrated focal alterations and consequent NF compaction associated
with sites of traumatically-induced axolemmal permeability changes (Povlishock et al.,
1997; Okonkwo et al., 1998).
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While these studies focused on MT and NF pathology, observations of direct
MF disruption have not been as forthcoming; however, membrane cytoskeletal
pathology has been observed indirectly using routine immunohistochemistry targeting
spectrin breakdown products that result from TBI-induced proteolytic degradation. A
predominant group of proteases implicated in TAI pathogenesis are the calciumactivated neutral proteases known as calpains. When intra-axonal calcium levels reach
sufficient concentrations, calcium binds to the inactive calpain molecule, resulting in
activation of the protease (Kampfl et al., 1997). Using antibodies targeting calpainmediated spectrin proteolysis (CMSP) products, Buki and colleagues demonstrated a
spatiotemporal correlation between focal, intra-axonal CMSP and NF compaction
following TBI, implicating calpain activation in TAI pathogenesis and spectrin as a
target for this pathological activation (Buki et al., 1999). Another proteolytic molecule
activated following TBI is the cysteine protease caspase-3 (Yakovlev et al., 1997;
Raghupathi et al., 2000; Yakovlev and Faden, 2001). Caspase-3 activity has been
indirectly documented in traumatically injured axons using antibodies targeting the
specific caspase-3-mediated breakdown product of spectrin (Buki et al., 2000).
Taken together, TBI-induced protease activation destabilizes the axon within the
central region (MTs 1 NFs) and at the membrane cytoskeleton (MFs / spectrin).
Cytoskeletal destabilization contributes to continued axolemmal instability following
the initial transient perturbation, allowing for further ionic dysregulation and increased
calcium entry that stimulates ongoing pathology. This cycle of membrane instability
followed by cytoskeletal degradation culminates in axonal disconnection due to collapse
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of the cytoskeletal network. It is important to remember that axonal disconnection is
delayed relative to the initial trauma. Delayed / secondary axotomy is caused by the
time needed to activate pathological cascades ultimately leading to cytoskeletal
collapse. This delayed pathological process is the focus of the next section and as will
be discussed in Chapter 2, TAI within the perisomatic domain results in an ultra-rapid
secondary axotomy with delay times significantly shorter than those reported in
previous studies.

Traumatic Axonal Injury - The Somatic Response and Axotomy
TAI leading to axotomy and disconnection may be generated by a variety of
experimental methods. Within the context of DBI, application of shear and tensile
forces to the whole brain results in axonal pathology at various anatomical loci. These
initiating forces may not immediately sever axons. Rather, they may stimulate the
aforementioned pathological processes with evidence of axonal damage visible only
after sufficient time has passed allowing for pathway activation. The time needed for
pathway activation results in delayed disconnection which is the hallmark characteristic
of secondary axotomy. On the other hand, axonal disconnection via direct surgical /
mechanical severance is classified as primary axotomy in that the injury to the axon is
the initiating pathology as opposed to a consequence of trauma.
Initial studies of axotomy and its related consequences employed direct
severance of axonal tracts due to its relative ease and specificity (Cajal, 1914;
Lieberman, 1971; Barron, 1983). Although this methodology is significantly different
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from diffuse injury, information gathered from these studies may be used to begin to
discern TAI-mediated secondary axotomy pathogenesis. Within one week following
transection, axotomized facial neurons displayed swelling of the soma with peripheral
displacement and deformation of the nucleus (Kreutzberg, 1995). These morphological
changes are grouped under the term chromatolysis, also known as the axon reaction. In
addition to altered morphology, axotomized neurons also undergo subcellular changes
including peripheral nuclear displacement and loss of Nissl bodies. Nissl bodies, which
are parallel arrays of rough endoplasmic reticulum, are either lost or much shorter than
normal and are no longer arranged in a parallel fashion. Related extra-neuronal changes
include glial profiles around somata and dendrites with concomitant loss of pre-synaptic
terminals, a process known as synaptic stripping. Although the causes of these
phenomena remain topics of debate, the favored explanation for this response following
axotomy is the interrupted supply of trophic factors conveyed to the soma by retrograde
transport.
Interestingly, axotomized neurons in the PNS are capable of regenerating axons
and achieving functional reinnervation of targets given the appropriate conditions;
however, it is well established that CNS neurons are not able to regenerate axons
although various experimental manipulations may create permissive environments in
which limited neurite outgrowth is visible. Comparative studies of central and
peripheral neuronal axotomy have revealed different as well as common responses
(Barron, 1983; Kreutzberg, 1995). Among the factors modifying the neuronal response
to axotomy are: the species and age of the animal; nature of the lesion (crush,
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transection, etc.); contact with the distal stump; the type of neuron; and the proximity of
the lesion with respect to the soma. This last factor is of particular interest to the current
dissertation. Primary lesions applied closer to the soma result in a more rapid reactive
response and increased cell death (Egan et al., 1977; Villegas-Perez et al., 1993). For
example, transection of the corticospinal tract in the thoracic (McBride et al., 1989),
cervical (Barron and Dentinger, 1979), or medullary spinal cord (Merline and Kalil,
1990) results in delayed atrophy rather than cell death. However, lesions in the internal
capsule, much closer to the somata, result in increased cell death relative to spinal cord
lesions (Giehl and Tetzlaff, 1996; Bonatz et al., 2000). Similar studies using optic nerve
and rubrospinal tract transections suggest that the distance of axotomy affects the cell
death rate with lesions closer to the cell bodies resulting in increased cell death / loss
(Liu et al., 2003; He et al., 2004).
While these studies examined lesion paradigms, a landmark study by Singleton
and colleagues explored the affects of diffuse trauma on axonal injury within the
perisomatic domain (Singleton et al., 2002). Utilizing a rat midlinelcentral fluid
percussion injury model of moderate severity, TAI and related axotomy was localized
to within 40 - 60 pm of the sustaining soma. In contrast to previous transection-induced
primary axotomy studies which generated neuronal atrophy and death, DBI-mediated
perisomatic TAI did not result in acute neuronal death. Rather, subcellular changes
associated with impaired protein synthesis were observed as well as evidence of
potential somatic reorganization and repair. As early as 30 minutes following injury,
perisomatic TAI was evident within the mediodorsal neocortex, hippocampal dentate
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gyms, and dorsolateral thalamus. While not the focus of the Singleton communication,
select axonal swellings appeared continuous with their downstream segments while
others appeared disconnected. These observations prompted the current investigation
into the spatiotemporal and ultrastructural characterization of TAI and related axotomy
within the perisomatic domain which is discussed in Chapter 2.

Traumatic Axonal Injury - Wallerian Degeneration
TAI-mediated axotomy results in loss of axonal continuity. While the axonal
segment proximal to the site of injury and disconnection remains continuous with the
soma, the distal segment now exists in isolation. Presumably, the proximal segment is
sustained through its continuity with the soma; however, the distal segment degenerates
due to loss of somatic trophic support. Degeneration of the distal axonal segment takes
place via a process termed Wallerian degeneration, named for Augustus Waller who
first described this phenomenon (Waller, 1850). Wallerian degeneration is a complex
sequence of events that involves axonal degradation, reactive changes in glial cells, and
phagocytic responses by macrophage-lineage cells (Griffin et al., 1995). It begins with
enzymatic proteolysis of the axonal cytoskeleton and is a relatively rapid process which
presumably clears the way (at least in the PNS) for potential axonal regeneration.
The events of Wallerian degeneration are sequential and may be arbitrarily
divided into stages (Griffin et al., 1995) although the overall process is a continuum of
change meaning different stages may be observed within a given tissue section. From
observations based on an axonal transection model, Stage 1 immediately follows
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transection and is characterized by the apparent survival of the distal axonal segment.
There is accumulation of intra-axonal organelles at both ends of the distal segment due
to continued bidirectional transport. The duration of Stage 1 varies depending on
species, length of the distal stump, temperature, and the nature and location of the axon.
There is some question as to whether distal segments in the PNS or CNS survive longer
following disconnection although a recent study suggests that axonal resealing
following transection takes longer in the CNS which has implications for distal segment
stability (Ahmed et al., 2001). Studies using a mutant (Ola) mouse with slow Wallerian
degeneration have also provided a wealth of information concerning this degenerative
process and will allow for continued studies of Wallerian change (Lunn et al., 1989;
Perry et al., 1990).
Stage 2 involves granular disintegration of the axoplasm and axonal breakdown.
The conversion of axoplasm into fine particulate and amorphous debris represents
cleavage products of the cytoskeleton. This change is believed to occur in an explosive
fashion as suggested by the rarity of observing partial stages of this process. Although
debris is the primary finding, remaining axolemma and mitochondria are also found
within axons that have undergone cytoskeletal disintegration. It is thought that
cytoskeletal degradation spreads distally from the site of axotomy with time (Lubinska,
1977) and is a calcium-dependent enzymatic process (see previous section).
Stage 3 closely follows axonal breakdown and is both similar and different
within the peripheral and central nervous systems. During this stage, recruitment /
activation of glial cells and macrophages takes place in both the PNS and CNS.

However, breakdown of the blood-nerve barrier occurs immediately following
cytoskeletal degradation in the PNS while there is little blood-brain barrier breakdown
in the CNS following degradation. In the PNS, Schwann cell responses include entry
into the cell cycle, alteration of protein synthesis, and formation of chains of
interdigitated cells called Bungner bands. Glial responses in the CNS include microglial
expression of activation markers and increased glial fibrillary acidic protein (GFAP)
expression by astrocytes. Macrophages in each nervous system express major
histocompatibility complex (MHC) molecules. PNS macrophages are derived from the
circulation via blood-nerve barrier breakdown while CNS macrophages appear to be
recruited primarily from dedifferentiation of resident microglia although entry from the
vasculature and/or perivascular locales may also contribute to observed populations.
Macrophage origins as well as responses to DBI and its associated pathology are
addressed in Chapter 3.
Stage 4 represents the clearance phase during which debris is removed via
immune cell-mediated phagocytosis and replaced by regenerating axons in the PNS or
by fibrillary glial processes in the CNS. While PNS axons regenerate and use molecular
cues from degraded pathways to guide their progression, CNS axons make limited
attempts at regrowth before ultimately terminating this process. Ultimately, glial
processes replace sites of former axons and may collectively form a glial scar which is
hostile towards promoting CNS axonal regeneration.
The temporal progression of Wallerian degeneration is dependent on several
factors including species examined and anatomical location. Studies of neuronal injuries
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in humans reveal evidence of continuing Wallerian change that persists for months to
years post-injury as demonstrated by myelin breakdown products downstream of the
injury site (Strich, 1968; Becerra et al., 1995; Buss et al., 2004). In lower order animals,
Wallerian degeneration proceeds at a faster pace although the degenerative timeline
outlined in Chapter 2 is significantly faster than those previously reported (George and
Griffin, 1994; Pesini et al., 1999; Buss and Schwab, 2003). Wallerian change proceeds
more quickly in the PNS than in the CNS, presumably conferring a regenerative
advantage to PNS axonal regrowth by creating a pathway for potential regeneration
(Griffin et al., 1995). To date, studies of Wallerian degeneration in the CNS come
mainly from spinal cord injury models or in vitro transection of dorsal root ganglia.
Evidence of Wallerian degeneration linked to TAI within the brain parenchyma is
discussed in Chapter 2.

GLIAL RESPONSE TO TRAUMATIC BRAIN INJURY: GENERAL
INTRODUCTION
In addition to TBI-induced neuronal damage and consequent degeneration, there
is a corresponding glial response to brain trauma. For example, as mentioned in the
previous section, the importance of glial cell activation in Wallerian degeneration has
been well documented, especially within the context of axonal debris recognition and
removal. Before addressing specific glial responses to TBI, a brief introduction of glial
cells is provided to familiarize the reader with the various cell types within this
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classification. This is followed by both historical and more current reviews of microglia,
the specific cell type which is the focus of this dissertation. (Note: A point of
clarification is necessary prior to beginning this section. Microglia are often discussed
in the literature together with macrophages in that following activation by an
appropriate stimulus, microglia adopt macrophage-like qualities and for all intents and
purposes, transform themselves into macrophages or at least, macrophage-like cells. It
is important to distinguish these endogenous brain macrophages from peripheral blood
monocyte-derived macrophages. Thus, in an attempt to provide clarity, this dissertation
may refer to "microglia / macrophages" when referencing endogenous brain cells and to
distinguish these cells from those macrophages derived from the peripheral blood.)
Glial cells within the CNS are classified as either macroglia (e.g.
oligodendrocytes, astrocytes, and ependymal cells) or microglia, with each cell type
having unique form and functions. Oligodendrocytes produce myelin sheaths that
insulate CNS axons, astrocytes have multiple functions including cytoskeletal support,
repair following injury, and transport mechanisms while ependymal cells line the brain
ventricles and the spinal cord central canal. While macroglia provide primarily neuronal
support functions, microglia are responsible for CNS surveillance and subsequent
inflammation, phagocytosis, and removal of extrinsic CNS content via activation and
conversion to a macrophage-like phenotype. Glia differ from neurons in that they
possess no synaptic contacts and retain the ability to divide throughout life, particularly
in response to injury (Raine, 1999). The term "reactive gliosis" is used to describe the
response of glial cells to neuronal tissue damage and implies, at the cellular level, that
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glial cells react to signals that arise from injured neurons (Streit et al., 1999). While the
glial response to traumatic injury relies on both neuronal signaling as well as intergliotic
communication, one must focus on specific cell types to begin to discern this complex
process. In that oligodendrocytes typically do not show reactive changes after CNS
injury (Ludwin, 1997) and given the highly variable astrocytic responses to trauma, this
dissertation focuses on the neuroinflammatory responses of microglia / macrophages to
DBI and its related TAI pathogenesis. Therefore, discussion is limited to rnicroglial /
macrophage responses with the recognition that no glial response occurs in isolation.

Microglia: Historical and Current Knowledge
It is important to first provide some historical context concerning microglia /
macrophages before discussing their responses to DBI and its related pathological
sequelae. Microglia were first identified in the late 1890's and early 1900's by a variety
of scientists including Nissl (1899), Robertson (1900), and Alzheimer (1904) although
their true identity was not elucidated until del Rio Hortega introduced his silver
carbonate staining method in 1932 which allowed microglia to be distinguished from
oligodendrocytes based on their respective structures (del Rio Hortega, 1932). Del Rio
Hortega observed that microglial distribution throughout the brain parenchyma was
uniform although cells were preferentially located near neurons and blood vessels. (It
was later determined that microglia at perivascular locales were in fact macrophages
which had entered from the peripheral blood.)
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It was not until the 1970's that microglia were determined to have a mesodermal
origin and invade the CNS when the vascular supply is developing during
embryogenesis. Cammermeyer's observation of microglia within the CNS of germ-free
rats proved that microglia were normal CNS components and not induced by brain
injury (Cammermeyer, 1970). Since these initial observations, it has been determined
that microglia: 1.) are derived from circulating monocytes or precursor cells to the
monocyte-macrophage lineage that originate in bone marrow; 2.) constitute

- 10 - 20

percent of the neuroglial population being less numerous in white than in grey matter;
3.) share many marker antigens with circulating monocytes, down-regulating them in

the resting state with up-regulation of their expression following an appropriate
stimulus; 4.) are dynamic cells which display phenotypic heterogeneity ranging from
highly ramified, small cell body resting morphology to ameboid, enlarged cell body
activated morphology; 5.) are not the only source of brain macrophages depending on
the nature and severity of brain injury which may allow for peripheral blood-derived
monocytes 1 macrophages to enter the parenchyma (Barron, 1995). Unlike neurons,
microglia are capable of proliferation. Thus, resident microglia remain within the brain
throughout life and are the first line of defense following trauma. In response to CNS
injury, microglia may undergo enhanced proliferation and localize to an injury site if
presented with appropriate mitogenic and chemotactic stimuli.

Microglia are the ubiquitous resident population of immune cells within the
CNS parenchyma (Raivich et al., 1999). Long thought to be quiescent until stimulated
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by an appropriate signaling molecule(s) and therefore given "resting" versus "active"
phenotype designations, more recent studies suggest that "resting" microglia actively
survey their extracellular environment via small projections from their cell surface
irrespective of brain pathology (Davalos et al., 2005; Nimmerjahn et al., 2005). As
such, resting microglia morphology is characterized by a small cell body with long,
ramified processes: in white matter, processes are oriented parallel to the nerve fibers
while in grey matter, they display a stellate morphology (Compston et al., 1997). In this
resting state, microglia typically occupy non-overlapping territories approximately 30 40 pm in diameter and are found evenly distributed throughout the entire parenchyma
although subtle regional differences exist. From an ultrastructural standpoint, microglia
typically have either an oval or elongate shaped nucleus with clumps of chromatin
beneath the nuclear envelope and throughout the nucleoplasm. Its granular endoplasmic
reticulum reveals cisternae which are long and narrow and often wind tortuously
through the cytoplasm. Dense laminar bodies, homogeneous droplets, lysosomes, and
lipofuscin are commonly encountered in the cytoplasm (Peters et al., 1991).
The role of microglia in the CNS immune response is to recognize and remove
pathogens as well as cellular debris, thus facilitating healing within damaged areas of
the brain parenchyma although they also have other related functions (Kreutzberg,
1996). In response to various types of brain pathology including neuronal damage,
microglial activation involves stereotyped changes which include increased cell body
size, thickened proximal processes, decreased distal branch ramification, and
differentiation towards a more macrophage-like phenotype (Raivich et al., 1999). For

39

example, if neurons die, microglia will transform into brain macrophages and remove
the dead cells. However, if neurons recover, active microglia may revert back to the
resting phenotype (Streit et al., 1999). Following activation, the distinction between
microglia and macrophage-like cell phenotype is subtle and is typically made by
morphological appearance and expression of cell surface molecules. Resting microglia
have a down-regulated immunophenotype adapted to the acute sensitivity of the CNS
microenvironment (Kreutzberg, 1996); however, upon appropriate stimulation,
microglia are actively transformed to a macrophage phenotype and express molecules
such as major histocompatibility complex (MHC) and CD45 (leukocyte common
antigen) on their cell surface (Berry et al., 2002). The microglial reaction to brain injury
is graded, with more severe injury resulting in greater activation and dedifferentiation to
macrophages.
In studies using a facial nerve axotomy model which involves a primary lesion
but lacks blood-brain barrier disruption, Kreutzberg and colleagues demonstrated
microglial proliferation and ensheathment of the lesioned nerve with interposing
processes between afferent synaptic terminals and the neuronal surface (Kreutzberg,
1995). This phenomenon, known as synaptic stripping, is believed to confer an adaptive
advantage in terms of neuronal reorganization following injury by allowing the injured
neuron to recover without the additional burden of constant synaptic input. In addition
to deafferentation of the injured neuron, ensheathment also places microglia within
close proximity to the injured cells. This proximity may be essential for facilitating
specific microglia - neuron interactions, such as the delivery of microglial-derived
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trophic factors that promote neuronal survival or toxic factors leading to expedited cell
death (Streit et al., 1999).
There is strong evidence to support microglial - neuron interactions within the
context of neuronal injury. It is conceivable that microglia may have dual responses to
trauma with the nature of injury dictating the manner in which microglia interact with
injured neurons. In a model proposed by Streit and colleagues, microglia may take a
perineuronal position based on chemotactic signals released by injured neurons. If the
nature of injury is reversible, signals released by the neuron may induce production of
trophic factors by perineuronal microglia. In the event of irreversible injury, neuronderived signals may cause microglia to produce neurotoxic factors that may speed
neuronal cell death thus facilitating phagocytosis by the prepositioned microglial cell
(Streit et al., 1999). Although close approximation between microglia and neurons is
found in the normal CNS (Palacios, 1990; Peters et al., 1991), this proximity is
highlighted following reactive microgliosis in response to neuronal injury.

Microglial Responses to Traumatic Brain Injury
Immune cell responses to focal TBI have received considerably more attention
than those related to diffuse TBI. Focal brain injury involves related contusion and/or
hemorrhagic-mediated tissue damage stemming from alterations of blood-brain barrier
(BBB) permeability and/or integrity. To date, various brain trauma models with focal
injury components, such as stab lesion, cortical contusion injury, and lateral 1
parasagittal fluid percussion injury, have been used to elicit neuroinflammatory
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responses. In 1976, Persson performed small stab wounds in the rat frontal lobe by
insertion of a glass capillary or steel needle and observed neurotrophilic leukocytes,
monocytes, and pericytes within the first post-operative week with subsequent
phagocytosis of necrotic debris during the first two weeks (Persson, 1976).
Interestingly, certain cells within the cavity were of intermediate morphology between
astrocytes and oligodendrocytes, similar to the "third type of neuroglial cell" recognized
by del Rio ~ o r t e g ain 1932 and suggestive of microglia. Profound reactivity was
observed in both invading hematogenous phagocytes (i.e. leukocytes and monocytes)
and neuroglial cells suggesting microglial cell activation. Using similar injury
methodology, Giulian and colleagues later observed activated microglia I macrophages
within and immediately adjacent to the stab lesion within hours post-injury via
phagocytic uptake of fluorescently labeled microspheres from the lesion (Giulian et al.,
1989). More comprehensive analyses of immune cell responses to cortical cryolesion
injury revealed immunoreactive microglia at 1 - 3 d post-injury within the lesion rim,
the border zone between cerebral cortex and underlying white matter, and thalamic
nuclei (Hermann et al., 2000), indicating microglial responsiveness at the injury site as
well as within areas remote from the primary pathology. Based on these and other
related studies, progressive axonall Wallerian degeneration and neuronall glial cell
death have been recognized as primary stimulants of immune cell activation and
consequent phagocytic removal of debris (Streit et al., 1999).
In terms of microglial responses to DBI, Carbonell and Grady provided regional
and temporal characterization following severe lateral FPI in the mouse (Carbonell and
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Grady, 1999). Microglial activation was consistently observed within regions of
neuronal injury including the ipsilateral cortex, hippocampus, and thalamus by 24 hrs
post-injury. Interestingly, the level of injury severity led to subdural hematoma
formation in all injured animals, indicated that a significant focal injury accompanied
the observed diffuse pathology. Other studies have demonstrated microglia 1
macrophage activation and clustering within various axonal injury loci following
diffuse TBI although cellular interactions at these sites were not characterized
(Oehmichen et al., 1999; Csuka et al., 2000). Microglial clustering was observed
infrequently while macrophage immunoreactivity was relegated to vascular and
perivascular locales.
Irrespective of the mechanism of injury, microglia undergo activation and
adhesion to damaged neuronal structures ultimately transforming into macrophage-like
phagocytic cells that remove debris. Phagocytosis is observed during the later stages of
Wallerian degeneration via the removal of disconnected axons and myelin as well as in
the removal of dead neurons, frequently leading to the formation of microglial nodules
consisting of 3 - 20 microglial phagocytes (Raivich et al., 1999).
Given the lack of information on DBI-mediated neuroinflammatory responses,
this dissertation focuses on the microglial 1 macrophage responses to DBI within loci
marked by TAI and uncomplicated by focal pathology such as acute neuronal cell death,
overt contusion, and hemorrhagic-mediated tissue damage. These observations and
subsequent discussion provided in Chapter 3 illustrate the differences between
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neuroinflammatory responses to focal and diffuse injury and suggest that indicators of
TBI may inadvertently overlook and thus underestimate the extent of diffuse pathology.

STATEMENT OF PURPOSE
In the preceding chapter, we have attempted to provide a detailed analysis of our
current understanding of the pathobiology of TBI, particularly in the context of DAI
which, as stated previously, is a major player in the morbidity and mortality associated
with TBI. Our understanding of the pathogenesis of TAI has improved vastly, as has
our understanding of its anterograde and retrograde consequences in terms of the
ensuing neuronal somatic and Wallerian responses. Yet, many questions remain in
relation to these anterograde and retrograde responses. For example, it appears
counterintuitive that the perisomatic axotomy described in the diffusely injured brain
does not result in rapid neuronal cell death that would have been anticipated based upon
the use of experimental axonal transection paradigms. Such a fundamental difference
suggests that the pathobiology of perisomatic axotomy versus physical transection is
dissimilar, potentially explaining the unanticipated finding of neuronal perturbation
without lethality. This dissertation seeks to explore this issue in the context of diffuse
TBI. Through the use of multiple structural and tracer approaches, Chapter 2 seeks to
explore if the rapidity of disconnection associated with perisomatic axotomy is the
critical variable or alternatively, is it the integrity of the axolemma as it progresses
through various phases of modification, resulting in axonal disconnection. Further, in
that the preservation of these perisomatically injured neuronal soma would suggest a
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non-lethal Inon-widespread immune response, Chapter 3 also directly investigates this
issue in the context of diffuse TBI. Here, we attempt to compare and contrast the nature
of the subsequent neuroinflammatory response triggered by diffuse injury to more
destructive tissue tearing involved with focal injury-mediated transection. Collectively,
the conduct of these studies seeks to provide further insight into the complex
pathobiology associated with DAI, explaining the precise nature of perisomatic axonal
failure, its anterograde and retrograde responses, as well as the neuroimmunological
sequelae associated with these events. It is hoped that these findings, together with
others emerging in the field, will help improve our understanding of patients sustaining
DAI and their ultimate therapeutic management.

Chapter 2

TRAUMATIC AXONAL INJURY IN THE PERISOMATIC DOMAIN TRIGGERS
ULTRARAPID SECONDARY AXOTOMY AND WALLERIAN DEGENERATION

Introduction
Traumatic brain injury (TBI) remains a leading cause of death and disability,
especially in children and young adults (Sosin et al., 1995; Kraus et al., 1996; Langlois
et al., 2004). Within this context, diffuse brain injury (DBI) occurs via rapid cranial
acceleration-deceleration with or without impact and generates little overt pathology in
comparison to focal lesions (Adams, 1992; Meythaler et al., 2001; Hardman and
Manoukian, 2002). A significant component of DBI is diffuse axonal injury (DAI)
which contributes to the associated morbidity and mortality (Christman et al., 1994;
Graham et al., 2002). Traumatic axonal injury (TAI), the experimental counterpart of
DAI, is characterized microscopically by focal impairment of axonal transport leading
to progressive axonal swelling and disconnection over several hours post-injury
(secondary axotomy) due to cytoskeletal misalignment and collapse via neurofilament
compaction, microtubule loss, and disruption of the subaxolemmal spectrin network
(Povlishock, 1992; Pettus and Povlishock, 1996; Povlishock and Pettus, 1996;
Okonkwo et al., 1998). Proposed mechanisms of moderate to severe TAI pathogenesis
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include traumatically induced transient perturbation of the axonal membrane allowing
for massive calcium influx which stimulates pathological cascades targeting the axonal
cytoskeleton for degradation (Povlishock and Pettus, 1996; Buki et al., 1999; Buki et
al., 2000).
Although considerable information has been generated concerning TAI and its
pathogenesis, particularly in long tract axons of the brainstem, it has been difficult to
evaluate the consequences of TAI in terms of the related neuronal somatic fate that also
must contribute to any ensuing traumatically induced morbidity. To better explore this
issue, our laboratory recently utilized a midlinelcentral fluid percussion injury (cFPI)
model to study the neuronal somatic response to DBI-mediated axotomy that occurred
in the perisomatic domain (Singleton et al., 2002). Using this model, perisomatic
axotomized fibers were localized to within 40 - 60 pm of the sustaining somata and
were found within distinct anatomical loci, namely the neocortex, hippocampus, and
thalamus. Contrary to expectations based on the existing literature of experimental
transection-induced primary axotomy (Barron, 1983; Kreutzberg, 1995), perisomatic
traumatic axotomy did not result in acute neuronal cell death. Rather the related somata
revealed impaired protein synthesis followed by neuronal cell reorganization and repair
(Singleton et al., 2002). Based on these unanticipated, non-lethal neuronal responses,
we questioned whether the structural and related subcellular changes associated with
perisomatic TAI significantly differed from those TAI changes previously described
within brainstem fiber tracts. To this end, we followed the course of this perisomatic
axotomy, focusing on its occurrence in discrete nuclei within the thalamus.
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Recognizing that axotomy within the long tract axons of the brainstem is
typically associated with impaired axonal transport and altered axolemmal permeability
(Pettus et al., 1994; Stone et al., 2004), we used immunocytochemical light and electron
microscopy as well as confocal microscopy with antibodies to P-amyloid precursor
protein (APP), a marker of impaired axonal transport, as well as extracellular tracers
(fluorescently-conjugated 10 kDa dextrans) normally excluded from intact axons to
critically evaluate the spatiotemporal and ultrastructural features of perisomatic TAI
following moderate cFPI. Routine LM analysis offered insight into the temporal course
of perisomatic axonal injury progression while EM semi-serial image reconstruction
permitted the characterization of the axonal subcellular responses at the site of injury in
addition to those proximal - distal changes ongoing in the axon cylinder. Parallel
confocal microscopy was used to explore post-injury alterations of axolemmal
permeability and its relation to focal APP accumulation at the axotomy site. Contrary to
expectations, these approaches demonstrated that the thalamic perisomatic TAI was
associated with an ultra-rapid axotomy followed by rapid initiation of Wallerian
degeneration. Further, despite the rapidity of this axotomy, this event was not
accompanied by overt alterations in axolemmal permeability.

Materials and Methods
Animal preparation and injury

To follow the pathogenesis of thalamic perisomatic TAI, animals were subjected
to moderate cFPI consistent with methods described previously (Dixon et al., 1987;
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Singleton et al., 2002). Adult male Sprague Dawley rats (375 - 400 gm) were
anesthetized with 4% isoflurane in 70% N 2 0 and 30% 02,intubated, and maintained on
a ventilator with 1-2% isoflurane for injury preparation. Intubated animals were placed
on a heating pad connected to a thermostat controlled by a rectal probe (Harvard
Apparatus, Holliston, MA) to maintain 37OC body temperature. To prepare the animal
for cFPI, the top portion of a Leur-Loc syringe hub of a 20 gauge needle, two fixation
screws, and dental acrylic were fixed to a midline craniotomy in the skull over the intact
dura and then connected to the injury device. Briefly, a 4.8mm circular craniotomy
along the sagittal suture midway between bregma and lambda was generated taking care
not to disrupt the underlying dura and superior sagittal sinus. The top portion of the
Leur-Loc hub (Becton Dickinson, Franklin Lakes, NJ) was cut away from the 20 gauge
needle, beveled, scored, and affixed over the craniotomy site using cyanoacrylate. After
confirming the integrity of the seal between the hub and the skull, fixation screws were
inserted into lmm holes drilled into the right frontal and occipital bones. Dental acrylic
(Hygenic Corp., Akron, OH) was applied around the hub and over the screws and
allowed to harden to provide stability during the injury induction. After the dental
acrylic hardened, the skin was closed over the hub with sutures, topical Lidocaine
ointment was applied, and the animal was removed from anesthesia and monitored in a
warmed cage until fully recovered (- 1 hr).
Prior to injury, the animal was again anesthetized with isoflurane. The incision
was quickly opened and the male end of a spacing tube was inserted into the Leur-Loc
hub. The female end of the spacer-hub assembly, filled with normal saline, was then
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inserted onto the male end of the fluid percussion device, ensuring that no air bubbles
were introduced into the system. A

- 2.1 atmosphere (1.9 - 2.3 atm) injury was

administered, consistent with brain injury of moderate severity (Dixon et al., 1987).
Injury preparation and induction were completed prior to the animal's recovery from
anesthesia. Following injury, the spacer-hub assembly was immediately removed en
bloc, bleeding was controlled with Gelfoam (Parmacia, Kalamazoo, MI), and the

incision was closed with sutures. Animals were monitored for spontaneous respiration
and, if necessary, ventilated with room air to ensure adequate post-injury oxygenation.
Post-injury recovery times for the following reflexes were recorded: toe pinch, tail
pinch, corneal blink, pinnal, and righting. Following recovery of the righting reflex,
animals were placed in a holding cage with a heating pad to ensure maintenance of
normothermia and monitored until the appropriate perfusion time. For sham-injured
control animals, the above steps were followed without injury induction. All injured
animals had righting reflex recovery times greater than 6 min compared to less than 2
min for sham-injured animals (data not shown). Experiments were conducted in
accordance with NIH and institutional guidelines concerning the care and use of
laboratory animals (IACUC).

Tissue preparation
Animals (n = 5 / injury group and 2 1 sham-injury group) were euthanized at t =
15,30,60, 180 rnin post-injury via an overdose of sodium pentobarbital IP (150 mglkg)
and transcardially perfused with 4% paraformaldehyde / 0.1 % glutaraldehyde in
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Millonig's buffer for immunocytochemistry. Following perfusion, brains were removed
and blocked in a coronal blocking device to include the thalamus with overlying
neocortex and hippocampus. The blocked region was then re-immersed in the same
fixative for 24 hours. Following postfixation, the blocked region was flat-mounted on a
metal plate with cyanoacrylate, embedded in agar, and sectioned in O.1M phosphate
buffer at a thickness of 40 pm using a vibrotome (Leica Microsystems, Bannockburn,
IL). Serial coronal sections (n = 60 sections at 40 pm 1 section) were collected starting
from 1600 pm caudal to the anterior commissure. Additionally, select blocked brains
were bisected along the midline, flat-mounted, and sectioned through the sagittal plane.
These sampling strategies allowed for a comprehensive examination of the thalamus
based on stereotactic coordinates relative to the anterior commissure (Paxinos and
Watson, 1986). Systematic uniform random sampling of coronal sections was employed
with every fifth section collected for a total of twelve sections per animal. Additional
tissue was stored in Millonig's buffer in 12-well culture plates (Falcon, Newark, DE).

Immunocytochemistry for light microscopy

Sections were processed with APP antibody to permit visualization of thalamic
perisomatic TAI and its spatiotemporal and ultrastructural characterization. Intra-axonal
APP moves via anterograde transport and pools at sites of impaired axonal transport,
thus serving as a marker of TAI (Stone et al., 2000). Sections were processed for APP
irnrnunoreactivity using an established protocol including modified microwave antigen
retrieval described previously (Stone et al., 1999).(Stone et al., 2000) Briefly,
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endogenous peroxidase activity within the tissue was first blocked with 0.3% H202in
PBS for 30 min. Sections were then processed using the temperature-controlled
microwave antigen retrieval approach, preincubated for 60 min in 10% normal goat
serum (NGS) with 0.2% Triton X-100 in PBS, and incubated overnight with C-terminus
specific APP (1: 1500; rabbit anti-C-APP; Zymed, San Francisco, CA) primary antibody
in 1% NGS in PBS. Sections were then incubated for 1 hr with biotinylated ratabsorbed goat anti-rabbit IgG secondary antibody (1 :200 Vector, Burlington, CA)
diluted in 1% NGS in PBS. Sections were visualized via incubation in avidinhorseradish peroxidase complex (Vectastain ABC Standard Elite Kit; Vector) for 1 hr
followed by 0.05% diaminobenzidine, 0.01% H202,and 0.3% imidazole in 0.1M
phosphate buffer for 10-20 min. Sections for light microscopic analysis were mounted
on gelatin-coated slides, dehydrated, and coverslipped while additional sections
underwent continued processing for EM. As an internal control, additional sections
were processed as described above; however, primary antibody was omitted from the
procedure. Images were captured using an Eclipse 800 microscope (Nikon, Tokyo,
Japan) fitted with a Spot-RT digital camera (Diagnostic Instruments, Sterling Heights,
MI).

Immunoelectron microscopy
Following LM processing, select sections were further processed for EM
analysis to ascertain related ultrastructural pathology. Following processing for APP
antibody, tissue was osmicated in 1% Os04 and then placed in graded alcohols and
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propylene oxide prior to placement in epoxy resin (Ted Pella, Redding, CA). Sections
were then embedded between plastic slides (Thomas Scientific Co., Swedesboro, NJ),
placed in 55OC oven for 3 days, and then scanned to identify immunoreactive axonal
swellings in continuity with their sustaining somata. Once identified, these sites were
removed, mounted onto plastic studs, and thick sectioned to the depth of interest using
an ultramicrotome (Leica Ultracut R; Wien, Austria). Semithin sections (1 pm) stained
with 1% Toluidine Blue were screened for evidence of perisomatic TAI and Wallerian
degeneration. Serial thin sections (70 nm) were then cut, picked up onto Formvarcoated slotted grids, and stained in 5% uranyl acetate in 50% methanol for 2 min. and
0.5% lead citrate for 1 min. The length and non-linear path taken by many thalamic
axons required reconstruction of semi-serial sections in order to examine the complete
axonal cylinder including the swelling site and proximal - distal axonal segments.
Images were captured using a JOEL 1230 electron microscope using either negative
film (Kodak, Rochester, NY) or digital camera (Gatan Digital Micrograph, Pleasanton,
CA) and were imported into Adobe Photoshop (Adobe Systems, San Jose, CA) prior to
publication to allow for thin section reconstruction.

Tracer studies and double-label immunojluorescencefor confocal microscopy
To determine the potential for focal alterations of axolemmal permeability
reminiscent of those described in the brainstem following injury as well as the potential
co-localization of altered permeability with impaired axonal transport and APP
accumulation, another population of animals (n = 3 / injury group and 2 / sham-injured
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group) received stereotactic injections of Alexa 488-conjugated lOkDa dextran (80 pl at
20 mglml) into the lateral ventricle prior to injury. Dextran was infused (Microinjection
Pump; Bioanalytical Systems, West Lafayette, IN) at a rate (2 pllmin) previously
recognized in our laboratory to maintain normal intracranial pressure. Tracer circulated
within the brain parenchyma for 3 hrs prior to injury induction. At t = 15, 30,60, and
180 min post-injury, animals were perfused with 4% paraformaldehyde and sections
were processed for APP immunocytochemistry as described previously. However, goat
anti-rabbit Alexa 594 secondary antibody (1: 1000; Molecular Probes, Eugene, OR) was
used to allow for simultaneous visualization of dextran and APP immunofluorescence.
Sections were mounted with an anti-fade aqueous mounting media (ProLong; Molecular
Probes, Eugene, OR) onto glass slides, coverslipped, and sealed with nail polish.
Images were captured using a confocal microscope (Leica TCS-SP2 AOBS; Leica
Microsystems, Bannockburn, IL) with appropriate excitation lasers, detectors, and
analysis software.

Axonal swelling measurements and statistical analysis

Axonal swelling diameter at each post-injury time point was quantified using
systematic random sampling within the thalamus. Using computer-assisted counting
software (CAST; Olympus, Copenhagen, Denmark) the thalamus was first outlined
bilaterally at low power (2X) after which a high power (100X with oil) objective was
used to count axonal swelling diameters at randomly assigned locations within the
defined thalamic region. Counts (n = 35) were obtained from a single animal at each
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time point using coronal tissue sections taken from comparable stereotactic coordinates
(approximately -3.60 mm relative to bregma) (Paxinos and Watson, 1986). Perisomatic
swellings or swellings in isolation were identified by APP immunoreactivity and
diameters were quantified at the maximal distance across the swelling by first focusing
through the z axis and then measuring the distance using a calibrated measuring tool.
Data were reported as mean + standard deviation and were analyzed using Welch
ANOVA and Tukey's HSD post-hoc. In addition to swelling diameter quantification,
swelling frequency versus diameter for the 15, 30, and 60 min post-injury time points
were plotted to provide additional insight into the temporal pattern of swelling
development.

Results
Sham-injury - Generalfindings

Macroscopically, sham-injured brains showed no evidence of compression,
contusion, or tissue loss. Tissue sections from sham-injured animals processed with
APP antibody and examined at the LM level demonstrated limited background staining
with the finding of only isolated immunoreactive somata. However, there was no
evidence of immunoreactive axons or swellings adjacent to these somata (data not
shown).
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Injury - LMfindings
The injured brains shared identical macroscopic features with sham-injured
brains with the exception of limited subarachnoid hemorrhage underlying the
craniotomy site and petechial hemorrhages within the corpus callosum. In tissue
sections, APP immunoreactive perisomatic thalamic axonal swellings were visible at all
post-injury time points. In addition to thalamic swellings, comparable perisomatic
axonal changes were found in the lateral neocortex and hippocampus, with other
swellings found scattered in the corpus callosum, subcortical white matter, and
brainstem. These findings were consistent with previous observations (Singleton et al.,
2002); however, they were not the focus of the current communication that centered
exclusively on thalamic change. Fifteen minutes post-injury, APP immunoreactive
axons were visible within thalamic nuclei, with most concentrated in the dorsolateral
(DL) quadrant. These axons revealed focal swellings reflected in the localized increase
of their relative axonal diameter. The swellings were within 40 - 60 pm of their somata
of origin and many were continuous with axonal immunoreactivity in both proximal and
distal directions, consistent with the maintenance of axonal continuity (Figs. 2-lA&B).
In contrast to these continuous irnrnunoreactive axonal profiles, other immunoreactive
perisomatic axonal swellings demonstrated no association with any immunoreactivity
distal to the swelling, suggesting axonal disconnection. Swelling diameter at 15 min
post-injury was 1.96 k 0.36 pm (mean k SD). By 30 min post-injury, imrnunoreactive
axonal swellings were now observed in the ventral posteriomedial (VPM) and
posteriolateral (VPL) nuclei together with the DL quadrant. These swellings were

Fig. 2-1. The low magnification microphotograph is provided only to orient the reader
to the dorsolateral thalamic locus (rectangle) in which perisomatic TAI is found. Higher
magnifications of this region at sequential post-injury time points demonstrate the
progression of perisomatic TAI via APP immunoreactivity. At 15 min post-injury
(A&B), immunoreactive axonal segments proximal and distal to swellings (arrowheads)
suggest axonal continuity despite focal impairment of axonal transport. Note that the
proximal segment immunoreactivity can be traced back to the corresponding soma of
origin. At 30 min post-injury (C), the focal axonal diameter at swelling sites
(arrowheads) is increased. The upper neuronal profile shows immunoreactivity distal to
the swelling while the lower profile lacks distal immunoreactivity, suggestive of axonal
disconnection. Note that by 60 min post-injury (D), most immunoreactive swellings
have lost distal immunoreactivity and that the focal axonal swellings (arrowheads) now
take on a rounded appearance. (Scale bar = 10 ym)
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similar to those seen at 15 min; however, they were increased in diameter (2.63 + 0.41
pm) and as such, were more intensely immunoreactive, consistent with continued
delivery of APP via anterograde transport. Although quantitative assessments were not
performed, there appeared to be increased numbers of these reactive swellings
compared to 15 min post-injury. Isolated immunoreactive axonal swellings revealed
continuity between the proximal and distal imrnunoreactive axonal segments; however,
the majority of immunoreactive axonal swellings at this time point demonstrated
continuity only with their proximal segments, without any evidence of downstream
axonal immunoreactivity (Fig. 2-IC). This observation was consistent with the premise
that these axonal swellings had become detached from their downstream segments. At
60 - 180 min, the above described thalarnic nuclei continued to demonstrate axonal
swellings that had expanded in diameter from 4.41 ? 0.87 pm at 60 min to 4.20 + 0.78
pm at 180 min. In this time interval, most axons with reactive swellings showed no
evidence of distal immunoreactivity consistent with complete axotomy and
disconnection (Fig. 2- ID).

Statistical analysis and progression of axonal swelling diameter

Statistical analysis of swelling diameter within each group showed a normal
distribution with unequal variances. Therefore, axonal swelling diameter measurements
from comparable thalamic regions for each of the four survival groups (15, 30,60, and
180 min post-injury) were compared using Welch ANOVA and found to be
significantly different (F(3,74) = 139.4, p value < 0.0001). Using Tukey's HSD post-
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hoc analysis, a progressive increase in swelling diameter over time post-injury was
confirmed. At 60 - 180 min post-injury, swelling diameter (4.41 k 0.87 pm and 4.20 k
0.78 pm respectively) was greater than at 30 min (2.63 k 0.41 pm) which, in turn, was
greater than at 15 min (1.96 k 0.36 pm). There was no significant difference between
swelling diameters at 60 and 180 min. The rapidity of axonal swelling was highlighted
by an approximate doubling in diameter when 15 and 60 min mean swelling diameters
were compared: 1.96 versus 4.41 pm respectively. To examine axonal swelling
progression, swelling frequency versus diameter was plotted as a function of time postinjury (Fig. 2-2). Swelling diameter showed a tendency to cluster at all time points and
increased as time post-injury increased. Similarly, axonal swellings appeared to expand
to a maximal diameter given the comparable mean diameter values at 60 and 180 min
post-injury.
EM findings

EM observations confirmed and supplemented those findings described at the
LM level. Specifically, as early as 15 - 30 min post-injury, a similar progression of
change was seen in all thalamic nuclei assessed. At these time points, focal axonal
swellings in continuity with their proximal and distal segments were seen, consistent
with LM observations. These swellings showed an intact yet expanded axolemma that
encompassed an organelle-laden mass composed primarily of mitochondria along with
smooth endoplasmic reticulum (SER) and vesicles, both containing immunoreactive /
electron-dense APP. Proximal to the swelling, the axonal cylinder appeared

Fig. 2-2. Graph of swelling frequency versus swelling diameter (pm) as a function of
time post-injury. Trend lines indicate swelling clustering by diameter as a function of
time post-injury. Mean diameter values demonstrate a statistically significant increase
over time. Note the relatively modest number of small swellings at 60 min post-injury
indicating minimal de novo swelling development in the later phases of injury. This data
suggests that perisomatic TAI occurs in the acute post-injury timeframe and that there is
an approximate doubling in swelling diameter within the first hour for those fibers
injured during the acute timeframe. (Note: 180 min data has been omitted for
simplicity)
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unremarkable showing normal axonal detail, while the related soma revealed no overt
subcellular changes. Similarly, the related distal axonal segment also appeared
morphologically normal. Of note was the fact that these perisomatic swellings typically
occurred just prior to the initiation of the myelin sheath although infrequently a myelin
investment was identified, consistent with involvement of the first internodal segment.
In contrast to these isolated continuous / non-axotomized fibers, many of the axonal

swellings seen at these time points demonstrated frank disconnection (Figs. 2-3 - 2-4).
This axonal disconnection, suggested at the LM level by the loss of immunoreactivity
distal to the swelling, was confirmed at the EM level via the loss of axonal continuity
distal to the site of axonal swelling. Consistent with LM findings, perisomatic swellings
were expanded containing numerous APP-laden vesicular profiles and abundant
mitochondria consistent with their continued delivery via anterograde axonal transport.
The related somata again appeared unremarkable. Although the proximal segment
between the soma and the swelling appeared structurally intact, some evidence of initial
change was reflected in the finding that many of the mitochondria within this axonal
segment were dilated. This was particularly so for those mitochondria approximating
the axonal segment immediately adjacent to the swelling (Fig. 2-3A). The swellings
themselves were surrounded by a continuous axolemma that encompassed a pool of
immunoreactive vesicles as well as mitochondria capping aggregated and disorientated
neurofilaments and microtubules (Fig. 2-4B). Immediately distal to the swelling, no
axonal continuity could be observed even when the sections were followed in semiserial order. Typically when downstream segments were identified via semi-serial

Fig. 2-3. This micrograph reveals a reactive axonal swelling with corresponding
proximal and distal segments 30 min post-injury (Bar = 5 pm). In rectangle A of Fig. 3,
separation of myelin lamellae can be seen within the proximal segment. Note that the
myelin sheath remains intact until just prior to the swelling. This segment, enlarged in
panel 3A, contains mitochondria demonstrating normal structural detail (single
arrowheads) as well as pathological swelling (double arrowheads). Linear
neurofilaments and microtubules are observed until the area of mitochondria1 pathology
at which point their orientation becomes disorganized. Swelling characteristics include
edema and loss of myelin 1 axonal ultrastructure. Granular electron-dense precipitate at
the site of the swelling is consistent with the pooling of APP immunoreactive vesicles
via impaired axonal transport. Axotomy is confirmed via loss of axonal ultrastructure
immediately distal to the swelling. Note that despite axonal disconnection, the distal
segment, seen in rectangle B of Fig. 2-3 and enlarged in panel 3B, remains
ultrastructurally intact with normal-appearing axonal morphology. (Bar = 2 pm)

Fig. 2-4. This micrograph illustrates a reactive axonal swelling and proximal segment
ultrastructure 15 min post-injury (Bar = 2 pm). Proximal segment ultrastructure, shown
in panel 4A corresponding to rectangle A in Fig. 2-4, appears morphologically normal
with linear neurofilaments along the longitudinal axis, together with microtubules and
compact, elongated mitochondria within an intact unmyelinated axolemma. Within this
segment, electron-dense APP immunoreactivity (arrowhead) can be seen within
scattered vesicles. In panel 4B corresponding to rectangle B in Fig. 2-4, swelling
ultrastructure is characterized by neurofilamentous disorganization (asterisks),
microtubule loss, and pooling of mitochondria. Within the swelling, the pooling of APP
immunoreactive vesicles (arrowheads) is consistent with an impairment of axonal
transport at this site. (Bar = 1 pm)
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section analysis, they were found up to 5 pm beyond the site of axotomy and axonal
swelling. Despite disconnection from their proximal segments, the tips of these distal
axonal segments were sealed by a continuous axolemma, with no evidence of structural
change. The distal segments appeared morphologically normal and contained an intact
cytoskeleton and organelles that included linear arrays of neurofilaments, microtubules,
and compact mitochondria within a well-defined axolemma (Fig. 2-3B). Axonal
swellings were seen at initial segments (Fig. 2-4), prior to initiation of the myelin
sheath, as well as within internodal segments (Fig. 2-3) approximating the somata of
origin as identified by myelin investment. Although quantitative studies were not
performed, swollen profiles were more commonly observed at the initial segment as
compared to the internodal segment. Remarkably, despite these processes of axonal
injury, swelling, and disconnection, the related brain parenchyma appeared unaltered.
The reactive changes occurring in the perisomatic axonal swelling and its disconnected
segment were not associated with local tissue tearing, overt structural damage, or
intrinsic vasculature disruption (Figs. 2-3 - 2-4).
By 60 - 180 min post-injury, the proximal axonal segment and related soma
remained morphologically intact, while axonal swellings demonstrated continued
cytoskeletal pathology, organelle accumulation, and axolemmal expansion (Fig. 2-5 2-7). The majority of axonal swellings now visualized were encompassed by a
continuous axolemma, with no evidence of downstream axonal continuity. Only
isolated swellings were found continuous with their distal segments which now were
devoid of organelles and contained amorphous debris suggestive of the initial stages of

Fig. 2-5. Evidence of axonal disconnection and anterograde 1 Wallerian degeneration is
seen at 60 min post-injury (Bar = 2 pm). In Fig. 2-5, the myelinated proximal segment,
seen in rectangle A, demonstrates normal morphology similar to injured axons at earlier
post-injury time points. The swelling, enlarged in panel 5A from rectangle A in Fig. 25, reveals edema and loss of axonal constituents although the overlying myelin sheath
remains intact and continuous with the proximal portion of the myelin sheath. Note that
local glial swelling and perivascular edema within the adjacent parenchyma can be
seen. Axonal disconnection is confirmed by the finding of myelinated, APP
irnrnunoreactive, edematous debris immediately distal to the swelling as seen in
rectangles B&C. The debris, enlarged in panels 5B&C, reveal axonal fragmentation and
vacuolization. Note the amorphous precipitate in an axoplasm devoid of organelles that
is bounded by a continuous axolemma. The more distal segment, enlarged in panel 5D
from rectangle D, reveals return of normal axonal ultrastructural detail including linear
neurofilaments and compact mitochondria within an intact axolemma. (Bar = 1 pm)

Figure 2-5

Fig. 2-6. The atypical finding of maintained axonal continuity at 180 min post-injury is
shown in this micrograph (Bar = 5 pm) which also reveals an example of internodal
involvement in the process of axonal injury. Note the presence of a swelling (asterisk)
that is continuous with both the proximal and distal axonal segments, encompassed by a
thinned, yet continuous, myelin sheath. Also note that the myelinated, proximal axonal
segment ultrastructure remains normal until immediately prior to the swelling. At the
intersection of the proximal segment and related swelling enlarged in panel 6A from
rectangle A in Fig. 2-6, linear neurofilaments and microtubules enter the swelling at
which point their orientation becomes disorganized. Further progression into the
swelling, enlarged in panel B from rectangle B, reveals neurofilament disorganization
(box within panel B) encompassing both normal and pathologically swollen
(arrowhead) mitochondria. Pooling of axoplasmic organelles and electron-dense APP
immunoreactive vesicles (double arrowhead) is consistent with impaired axonal
transport. The distal (although not disconnected) segment shows loss of axoplasmic
constituents and amorphous precipitate although portions of the myelin sheath remain
intact. These changes appear consistent with the onset of Wallerian degeneration. (Bar =
1~ m )

Figure 2-6

Fig. 2-7. In contrast to Fig. 2-6, Fig. 2-7 shows evidence of disconnection. Note that in
Fig. 2-7, the sustaining soma (N) can be seen in continuity with the proximal axonal
segment which is enlarged in panel 7A from rectangle A. The axonal swelling and
disconnection enlarged in panel 7B from rectangle B shows evidence of downstream
Wallerian change seen in panel 7C enlarged from rectangle C (Bar = 5 pm). Note that
the initial segment (panel 7A) ultrastructure seen in continuity with its sustaining soma
appears morphologically normal although periaxonal edema is present. Within this
segment, electron-dense APP immunoreactive vesicles are evident (arrowheads). At the
swelling (panel 7B), impaired axonal transport is marked by loss of neurofilament
linearity and microtubules along with pooling of immunoreactive vesicles (arrowheads).
Immediately distal to the site of swelling and disconnection, myelinated axonal debris
(panel 7C) is seen. Within this disconnected segment, granular amorphous content is
seen within the myelinated axonal cylinder. (Panel A&B Bar = 1 pm; Panel C Bar = 2
pm>

Figure 2-7
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Wallerian change (Fig. 2-6). In contrast to earlier time points, all distal disconnected
axonal segments now displayed evidence of pathological change that included axonal
fragmentation and vacuolization together with myelin disruption and separation,
pathologies consistent with Wallerian degeneration (Fig. 2-5B&C). The most distal
portions that could be identified revealed the loss of their intra-axonal components with
electron-dense amorphous precipitate observed within intact axonal cylinders (Fig. 27C). These events again occurred at the initial axonal segment although infrequent
internodal involvement was also recognized. As in earlier time points, these processes
occurred without evidence of tissue tearing; however, these perisomatic axonal changes
were now associated with local glial swelling and perivascular edema (Fig. 2-5).

Tracer studies

As noted, an extracellular tracer was used to assess the potential for
traumatically induced axolemmal failure as a prelude to swelling development and
axotomy. Additionally, following axonal disconnection, the tracer also provided the
added advantage of offering insight into the process of axonal disconnection and
potential membrane resealing. To explore these issues, confocal microscopy was
employed to examine fluorescently-conjugated 10 kDa dextran co-localized with APP
immunofluorescence.
In sham-injured tissue, APP immunofluorescence was identical to that described
by routine enzyme-linked LM immunohistochemistry. Limited somatic
irnmunofluorescence was observed with no evidence of immunoreactive axonal
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swellings. Following tracer administration, its diffusion throughout the parenchyma and
perivascular sleeves of the thalamus was apparent; however, there were no signs of
local axonal or neuronal uptake (Fig. 2-8A). In injured tissue, APP immunofluorescence
was consistent with characteristics of perisomatic TAI. As with our previous
observations, select swellings were found within continuous axons while others
appeared disconnected from their distal segments. Despite the dispersion of tracer
throughout the thalamic parenchyma prior to injury, no axonal tracer uptake was
observed at any post-injury time point. Further, there was no co-localization of tracer
and APP immunofluorescence at sites of axotomy identified by APP positive axonal
swellings lacking distal irnmunofluorescence (Fig. 2-8B). These findings suggested that
perisomatic TAI pathogenesis occurred not only independent of overt alterations of
axolemmal permeability but also that rapid axolemmal resealing or disconnection with
membrane closure occurred with axotomy. Consistent with previous reports from our
laboratory (Singleton and Povlishock, 2004), isolated somatic flooding was observed
following injury; however, this somatic flooding was consistently independent of
perisomatic TAI pathology with the caveat that the tracer entered these neuronal somata
via defects in their plasmalemmae.

Discussion
The results of this communication reveal, for the first time, the pathogenesis of
DBI-mediated perisomatic TAI with concomitant secondary axotomy and Wallerian
degeneration following moderate cFPI. Using a well-documented antibody marker of

Fig. 2-8. This confocal microscopic image illustrates that thalamic perisomatic TAI
occurs independently of overt alterations in axolemmal permeability. At 180 min postinjury, panel 8A is from a sham-injured animal receiving pre-injury extracellular tracer.
Note that the 10 kDa dextran (green) can be seen within the perivascular sleeves
(arrowheads) and surrounding parenchyma, while the APP immunoreactivity (red) is
limited to neuronal somata. In panel 8B, a perisomatic axonal swelling (double
arrowhead) can be traced to its sustaining soma. Swellings (double and triple
arrowheads) are surrounded by, but independent of, somatic flooding (single
arrowheads). Lack of dextran - APP co-localization at the site of swelling and
disconnection suggests either axolemmal sealing prior to disconnection or ultra-rapid
membrane resealing following axotomy. (Bar = 40 pm)
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impaired axonal transport (Stone et al., 2000), secondary axotomy and disconnection at
the site of injury were seen within the thalamus as early as 15 min post-injury, without
evidence of axonal tearing or related parenchymal disruption. Wallerian change
associated with the loss of axoplasmic constituents and ultrastructural integrity occurred
within the axonal segment distal to the site of disconnection by 60 - 180 min and was
accompanied by evidence of local edema and reactive glial change. The parallel
exclusion of 10 kDa dextrans from the site of this progressive axonal response to injury
demonstrated that perisomatic TAI was not accompanied by overt alterations in
axolemmal permeability. Analysis of the temporal progression of perisomatic TAI
revealed an increase in axonal swelling diameter over time with the suggestion of a
maximal swelling diameter at 60 - 180 min post-injury. Additionally, the finding of
modest numbers of small swellings at 60 min post-injury indicated that few de novo
axonal swellings occurred in the later phases of injury. Taken together, these findings
indicate that axonal injury, swelling, and detachment occur rapidly following traumatic
insult and that this progressive change occurs only within those fibers injured at the
moment of traumatic injury without delayed recruitment via secondary injury
mechanisms.
While others have explored TAI within the thalamus following parasagittal FPI,
these evaluations were initiated at 24 hrs post-injury in contrast to the much earlier
evaluations reported here (Bramlett et al., 1997). Further, previous studies from our
laboratory also demonstrated the occurrence of bilateral perisomatic TAI in the
thalamus following cFPI (Singleton et al., 2002). Yet, these studies neither evaluated
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the spatiotemporal progression of the TAI nor examined the related axonal
ultrastructural responses andlor any related axolemmal permeability change. It was
assumed that the repertoire of injury-induced change occurring within these perisomatic
axonal domains paralleled that previously described in the brainstem wherein focal
altered axolemmal permeability, neurofilament misalignment and compaction,
microtubule loss, mitochondria1 swelling, and secondary axotomy typically took place
over several hours post-injury (Pettus et al., 1994; Pettus and Povlishock, 1996). While
components of perisomatic TAI pathobiology parallel brainstem TAI in terms of
neurofilament / microtubule pathology and focal impairment of axonal transport
reflected in organelle and mitochondria1 pooling, several aspects of perisomatic TAI
pathogenesis appear unique.
While the initiating processes of TAI-related pathology have been documented
as early as 5 - 30 min following injury, its progression to disconnection in brainstem
axons has been typically described over a several hour period (Pettus et al., 1994;
Povlishock et al., 1997; Maxwell and Graham, 1997; Maxwell et al., 1999). However,
this timeframe within brainstem axons was not comparable to that seen within thalamic
perisomatic TAI wherein the ultra-rapid progression of axonal swelling and
disconnection represent an unexpected and novel finding. The reason for these
differences between perisomatic and long tract brainstem fibers is unclear; however, it
may be related to multiple factors. In contrast to brainstem TAI that is found primarily
within the major ascending and descending white matter tracts remote from their cell
bodies of origin, perisomatic TAI is found at the gray-white matter interface within the
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neocortex and thalamus, areas subjected to increased shearing during trauma, rendering
this locus selectively vulnerable to axonal injury (Smith et al., 1997; Meythaler et al.,
2001). Of additional relevance, the perisomatic injury typically occurred at or near the
initial segment of the axon prior to the initiation of the myelin sheath (Conradi, 1969).
Here the axon would be exposed to the forces of injury which could act on the
unprotected axolemma causing transient membrane perturbation with calcium influx
and the precipitation of calcium-mediated proteolytic pathways (Singleton et al., 2002).
Although 10 kDa dextran passage was not observed at this site, this does not preclude
the possibility of a more subtle membrane perturbation, allowing for calcium ion influx
with the exclusion of higher molecular weight species. Alternatively, an alteration of
sodium channels at the initial segment could also allow for traumatically-induced
abnormal sodium influx, triggering voltage-gated calcium channel opening and a
reversal of sodium-calcium exchange, leading to pathologically elevated intra-axonal
calcium concentrations (Lopachin and Lehning, 1997; Wolf et al., 2001).
In the current study, it is of note that no focal axolemmal permeability
alterations to the extracellularly applied 10 kDa dextrans occurred following
perisomatic axotomy. These observations contrast with previous findings in the
brainstem where focal axonal flooding with a relatively large molecular weight species
(horseradish peroxidase; 44 kDa) has been described as early as 5 min post-injury
(Pettus et al., 1994). In this regard, our observations are more consistent with Smith et
al. who, using in vitro dynamic stretch injury, demonstrated that axonal injury occurred
independent of 570 Da dye uptake (Smith et al., 1999). Complicating this issue is the in
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vivo work of Stone et al. who suggested that impaired axonal transport and altered

axolemmal permeability occurred within different populations of axons following TBI
(Stone et al., 2004) suggesting that not all injured axons demonstrate axolemmal
permeability change, at least to the relatively large molecular weight tracers used.
Conceivably, the axonal tracer flooding previously described within the brainstem may
delineate the more severe forms of TAI. Perhaps, the perisomatically injured axons
assessed in this study undergo more subtle pathological alterations of their axolemmae
allowing for focal ion (e.g. calcium, sodium) influx, resulting in localized cytoskeletal
pathology and impaired axonal transport.
Not only did this study fail to demonstrate any acute axolemmal permeability
changes to the tracer used but also, there was no evidence of tracer influx even in the
face of focal axonal swelling and disconnection. To date, virtually no information exists
concerning axolemmal resealing 1 repair following DBI-mediated axotomy. A recent
study examining transection-mediated CNS axon resealing, a paradigm quite dissimilar
from DBI, suggested delayed resealing (Ahmed et al., 2001). Work in non-neuronal
cells has demonstrated that the membrane resealing following injury involves calciummediated vesicular fusion, with the observation that membrane integrity can be
reestablished within seconds following injury (Terasaki et al., 1997; McNeil and Baker,
2001). In the current study, despite tracer dispersion within the thalamic parenchyma
prior to injury, there was no co-localization of dextran and APP immunofluoresence
within the swellings, suggesting that either axolemmal sealing occurred prior to
disconnection or that ultra-rapid membrane closure followed axotomy. The fact that we
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observed disconnected axonal swellings consistently enclosed by an intact axolemma
supports both possibilities. Thus, further studies targeting the axolemmal components
involved in membrane resealing / repair following secondary axotomy are needed to
decipher these complex biological issues.
In addition to the above described rapid progression of axonal swelling and
disconnection, the current study also provided unique information into the precise
sequence of Wallerian change triggered by this observed axonal pathology. Like the
processes of swelling and disconnection, the onset of Wallerian change was also rapid
in contrast to that described in the existing literature. Classic descriptions of Wallerian
change in the CNS of humans and higher order animals describe a process that is slow
to evolve and persists for months to years post-injury (Strich, 1968; Becerra et al., 1995;
Buss et al., 2004). Even in lower order animals and rodent models of TAI, this process
is much more delayed than described in the current communication. Maxwell et al.
provided the first ultrastructural evidence of Wallerian degeneration in the post-acute (>
1 day) timeframe using an optic nerve stretch injury model of TAI (Maxwell et al.,
2003). Similar to our findings, they reported altered ultrastructural morphologies
including lucent, abnormal mitochondria within injured axons, the separation of the
myelin lamellae, as well as amorphous content, flocculent precipitate, and lack of
axoplasmic organelles within the axonal segment distal to the swelling. However, the
timeframe during which these findings were described was different from the current
communication. Maxwell reported initial evidence of Wallerian change at 24 hrs postinjury; yet, our data suggests the onset of Wallerian change by 60 - 180 min. While
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different injury models may account for this time discrepancy, this issue requires
continued investigation.
Finally, an important question remains regarding the implications of the above
findings to our previous observations that the occurrence of perisomatic axotomy did
not elicit rapid neuronal death (Singleton et al., 2002) as had been suggested by
previous transection paradigms (Barron, 1983; Kreutzberg, 1995). We had assumed that
this finding was related to the likelihood that, similar to the long tract axons within the
brainstem, a slowly progressive axotomy within the perisomatic domain would shield
the related soma from rapid exposure to the ionic dysregulation and its adverse
consequences typically associated with physical transection models. In this context, our
finding of rapid disconnection was unanticipated and initially suggested that our
previous beliefs regarding subsequent cell death or survival were incorrect. However,
despite the rapidity of the detachment observed in the current communication, the fact
that detachment did not translate into rapid cell death suggests that cell death may not
be directly related to the actual speed of disconnection. Rather, the fact that this
disconnection occurred without related overt alterations in axolemmal permeability may
constitute the more significant finding. As such, it indirectly suggests that the
maintenance of membrane integrity may be pivotal to attenuating the onset of rapid
neuronal death as seen with transection wherein the axon cylinder itself remains
transiently yet fully exposed to the extracellular environment and its different ionic
milieu.
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In sum, the current communication builds on previous TAI studies and expands
TAI characterization to include thalamic perisomatic TAI with ultra-rapid secondary
axotomy and Wallerian degeneration within the context of DBI. Importantly, these
findings have implications for preclinical studies of therapeutic interventions attempting
to target pathological mechanisms during the delay prior to axonal swelling and
disconnection, a goal that may ultimately prove unattainable in the perisomatic domain.
This study again illustrates the complexity of TAI pathobiology and provides the
impetus for future studies of neuronal membrane repair mechanisms and potential
recovery following traumatic brain injury.

ADDENDUM TO CHAPTER TWO
Having evaluated the acute phase of perisomatic TAI pathogenesis, additional
studies were undertaken to examine the long-term fate of these injured neurons. A
previous study by Singleton and colleagues demonstrated that neurons injured within
the perisomatic domain did not progress to acute cell death (Singleton et al., 2002).
Therefore, we extended our observations to 28 d post-injury and utilized stereological
assessments of neuronal somatic volume as well as employed additional antibody
markers of neuronal health to determine what becomes of this uniquely injured neuronal
population. Neuronal measurements were taken from sham-injured tissue sections and
compared to measurements taken at 1,7, and 28 d post-injury. Our findings revealed a
statistically significant decrease in tissue region and neuronal nuclear volume at each
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post-injury time point when compared to sham control (article in preparation). These
findings suggest neuronal atrophic changes in response to DBI.
To further clarify mechanisms related to this observation, antibodies to neuronal
deafferentation / remodeling (e.g. PSD-93, PSD-95, GAP-43, synaptotagmin,
synaptophysin), intracellular protein synthesis (e.g. eif-2a(P), HSP-60, HSP-70), and
cell death / survival (e.g. TUNEL, Nitro-Tyr, activated caspase-3, P-Bad, cyt c, PARP)
were employed. While certain antibodies demonstrated immunoreactivity with regions
of TAI pathology (e.g. eif-2a(P), HSP-70) that were consistent with previous
communications from our laboratory (Singleton et al., 2002), the remaining antibodies
failed to demonstrate compelling evidence linking perisomatic TAI to their respective
mechanisms of action.
Given the atrophic but apparently non-lethal neuronal response to perisomatic
TAI, we then examined the corresponding microglia / macrophage responses within
diffuse injured brain regions to provide a more comprehensive study of DBI and its
related pathological sequelae as well as to compare / contrast this response to the
inflammatory response following focal TBI. Chapter 3 will outline the
neuroinflammatory response within specific anatomical loci known to elicit DBImediated TAI and uncomplicated by focal pathology. The relationship between
inflammatory cells and injured neurons will be discussed as will implications for the use
of neuroinflammatory responses as markers for DBI-mediated axonal pathology.

Chapter 3

NEUROINFLAMMATORY RESPONSES TO DIFFUSE TRAUMATIC BRAIN
INJURY

Introduction
The immune response to traumatic brain injury (TBI) involves microglia as well
as leukocytes recruited from the surrounding vasculature. To date, this immunological
response has been studied most extensively in the context of focal TBI despite the fact
that diffuse TBI remains the most significant component of the morbidity associated
with traumatic injury. Focal injuries, often associated with blunt force trauma, are
associated with cerebral contusions and hematomas while diffuse injuries, a common
result of motor vehicle accidents, depend on inertial forces and result in more subtle
scattered microscopic pathology. To date, the immune cell responses to experimental
focal brain injury have been studied extensively (Persson, 1976; Giulian et al., 1989;
Clark et al., 1994; Mathew et al., 1994; Hermann et al., 2000; Chen et al., 2003).
Additionally, limited studies have documented generalized immune cell responses to
diffuse brain injury (DBI) (Oehmichen et al., 1999; Csuka et al., 2000), yet both clinical
and experimental studies have been typically complicated by focal brain contusion and
related hemorrhagic components
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(Aihara et al., 1995; Soares et al., 1995; Carbonell and Grady, 1999) thereby allowing
leukocytes to enter the injured brain parenchyma via the overt disruption of the bloodbrain barrier (BBB). This contusion-related BBB disruption also permitted the
unregulated passage of stimulatory molecules from the vasculature complicating the
evaluation of glial activation.
Fortunately, in the experimental setting other animal models have been
developed to minimize the potential for contusion andor hemorrhage while maintaining
many of the important features of diffuse TBI, including diffuse axonal injury (DAI)
and its subsequent anterograde and retrograde consequences. Specifically, the use of
midlinelcentral fluid percussion injury (cFPI) in the rat allows for the generation of
traumatic axonal injury (TAI), the experimental counterpart of DAI, characterized by
the focal impairment of axonal transport leading to progressive axonal swelling and
secondary axotomy (Povlishock, 1992; Pettus and Povlishock, 1996; Povlishock and
Pettus, 1996; Okonkwo et al., 1998). Moderately severe cFPI can induce perisomatic
TAI (i.e. within 40-60 ym of the sustaining soma) allowing for the critical assessment
of both the retrograde neuronal somatic responses to injury as well as specific
anterograde 1 Wallerian responses as outlined in Chapter 2 (Singleton et al., 2002).
Using this model, TAI has been observed scattered within various anatomical loci,
including the mediodorsal neocortex, hippocampal dentate gyms, and dorsolateral
thalamus without any associated contusions andor hemorrhagic-mediated tissue
damage. These factors provided the opportunity to explore microglial 1 macrophage
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responses within diffusely injured brain regions uncomplicated by focal brain
pathology.
The present study provides imm~~nocytochemical
light, electron, and confocal
microscopic characterization of the immune responses to DBI in the absence of focal
tissue damage. Microglia within brain loci revealing TAI responded rapidly, albeit in an
initially uncoordinated fashion, via changes in their cellular morphology. This was
followed by their persistent activation and phagocytic activity. In contrast, the microglia
observed in non-TAI containing regions maintained a resting phenotype. Macrophages
displayed similar spatiotemporal responses to DBI and its associated TAI. Select
macrophages approximated scattered somata of traumatically injured neurons showing
evidence of somatic bouton disruption and loss. Taken together, these findings suggest
that neuroinflammatory responses to DBI with TAI may be distinct from those related
to more focal TBI pathology. These findings may have implications for post-mortem
histopathological evaluation of TBI and its characterization based upon specific
microglial / macrophage responses.

Materials and Methods
Animal preparation and injury
To explore microglial / macrophage responses to DBI, animals were subjected to
moderate cFPI consistent with methods described previously (Dixon et al., 1987;
Singleton et al., 2002). Adult male Sprague Dawley rats (375 - 400 gm) were
anesthetized with 4% isoflurane in 70% N 2 0 and 30% 02, intubated, and maintained on
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a ventilator with 1-2% isoflurane for injury preparation. Intubated animals were placed
on a heating pad connected to a thermostat controlled by a rectal probe (Harvard
Apparatus, Holliston, MA) to maintain 37OC body temperature. To prepare the animal
for cFPI, the top portion of a Leur-Loc syringe hub of a 20 gauge needle, two fixation
screws, and dental acrylic were fixed to a midline craniotomy in the skull over the intact
dura and then connected to the injury device. Briefly, a 4.8mm circular craniotomy
along the sagittal suture midway between bregma and lambda was generated taking care
not to disrupt the underlying dura and superior sagittal sinus. The top portion of the
Leur-Loc hub (Becton Dickinson, Franklin Lakes, NJ) was cut away from the 20 gauge
needle, beveled, scored, and affixed over the craniotomy site using cyanoacrylate. After
confirming the integrity of the seal between the hub and the skull, fixation screws were
inserted into lmm holes drilled into the right frontal and occipital bones. Dental acrylic
(Hygenic Corp., Akron, OH) was applied around the hub and over the screws and
allowed to harden to provide stability during the injury induction. After the dental
acrylic hardened, the skin was closed over the hub with sutures, topical Lidocaine
ointment was applied, and the animal was removed from anesthesia and monitored in a
warmed cage until fully recovered (- 1 hr).
Prior to injury, each animal was again anesthetized with isoflurane. The incision
was quickly opened and the male end of a spacing tube was inserted into the Leur-Loc
hub. The female end of the spacer-hub assembly, filled with normal saline, was then
inserted onto the male end of the fluid percussion device, ensuring that no air bubbles
were introduced into the system. A

- 2.1 atmosphere (1.9 - 2.3 atm) injury was
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administered, consistent with brain injury of moderate severity (Dixon et al., 1987).
Injury preparation and induction were completed prior to the animal's recovery from
anesthesia. Following injury, the spacer-hub assembly was immediately removed en
bloc, bleeding was controlled with Gelfoam (Parmacia, Kalamazoo, MI), and the
incision was closed with sutures. Animals were monitored for spontaneous respiration
and, if necessary, ventilated with room air to ensure adequate post-injury oxygenation.
Post-injury recovery times for the following reflexes were recorded: toe pinch, tail
pinch, corneal blink, pinnal, and righting. Following recovery of the righting reflex,
animals were placed in a holding cage with a heating pad to ensure maintenance of
normothermia and monitored until the appropriate perfusion time. For sham-injured
control animals, the above steps were followed without injury induction. All injured
animals had righting reflex recovery times greater than 6 min compared to less than 2
min for sham-injured animals (data not shown). Experiments were conducted in
accordance with NIH and institutional guidelines concerning the care and use of
laboratory animals (IACUC).

Tissue Preparation
Animals (n = 6 / injury group, 2 / sham-injury group, and 2 naive) were
euthanized at t = 6 and 24 hrs as well as 2,7, 14, 21, and 28 days post-injury via an
overdose of sodium pentobarbital IP (150 mglkg) and transcardially perfused with 4%
paraformaldehyde in Millonig's buffer for immunocytochemistry. Following perfusion,
brains were removed and blocked in a coronal blocking device to include the thalamus
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with overlying neocortex and hippocampus (Fig. 3-1). A previous study, as well as
observations from Chapter 2, has identified TAI scattered throughout these regions,
consistent with the occurrence of diffuse injury (Singleton et al., 2002). The tissue block
was flat-mounted on a metal plate with cyanoacrylate, embedded in agar, and sectioned
in O.1M phosphate buffer at a thickness of 40 pm using a vibrotome (Leica
Microsystems, Bannockburn, IL). Serial coronal sections (n = 60 sections at 40 pm /
section) were collected starting from 1600 pm caudal to the anterior commissure. This
sampling strategy allowed for a comprehensive examination of the neocortex,
hippocampus, and thalamus (Paxinos and Watson, 1986). Systematic uniform sampling
of coronal sections was employed with every fifth section collected for a total of twelve
sections per animal. Additional tissue was stored in Millonig's buffer in 12-well culture
plates (Falcon, Newark, DE).

Immunocytochemistryfor confocal microscopy
Double-labeling strategies were employed to permit simultaneous visualization
of microglia / macrophages and TAI, a key feature of diffuse TBI. To label microglia,
tissue sections were incubated overnight with lectin (Alexa 488 conjugated isolectin B4
from GrifSonia simplicifolia (5 pglml); Molecular Probes, Eugene, OR) in 20% normal
horse serum (NHS) in artificial cerebrospinal fluid (aCSF: 126 mM NaC1, 3 nlM KC1,
1.25 rnM NaH2P04, 2 mM MgC12,2 rnM CaC12, 10 mM glucose buffered with 26 rnM
NaHC03) consistent with previously described methods (Dailey and Waite, 1999;
Stence et al., 2001; Grossmann et al., 2002; Carbonell et al., 2005). TAI was then

Fig. 3-1. The low-magnification microphotograph is provided to orient the reader to the
diffusely injured brain loci revealing significant TAI that is uncomplicated by focal
pathology; A: mediodorsal neocortex, B: hippocampal dentate gyms, C: dorsolateral
thalamus. Activated microglia and macrophages were localized to these areas following
diffuse brain injury. In contrast, asterisks delineate related regions also sampled in the
current investigation that did not contain significant TAI or other forms of overt
pathology.
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visualized using antibody to the amyloid precursor protein (APP) as described below.
APP moves via anterograde transport and pools at sites of impaired axonal transport
thus serving as a marker of TAI (Stone et al., 2000). To ensure maintenance of lectin
binding, all steps of the lectin - APP double-labeling procedure were conducted in
aCSF.
To label macrophages, sections were first preincubated for 60 min in 10% NHS
with 0.2% Triton X-100 in phosphate buffered saline (PBS) and then incubated
overnight with macrophage (1:2000; mouse anti-rat CD68 (ED1); Serotec, Oxford,
England) primary antibody in 1% NHS in PBS / 2% bovine serum albumin (BSA).
After removal of the antibody solution, sections were rinsed and incubated for 2 hrs in
Alexa 488 goat anti-mouse IgG (1: 1000; Molecular Probes) with 1% NHS in PBS / 2%
BSA prior to processing for TAI.
For labeling TAI, sections were rinsed and incubated with 10% normal goat
serum (NGS) in PBS (except for lectin - APP processing which used aCSF) for 45 min
followed by an overnight incubation in C-terminus specific APP primary antibody
(1: 1000; rabbit anti-C-APP; Zymed, San Francisco, CA) with 1% NGS in PBS.
Sections were then rinsed and incubated for 2 hrs with Alexa 594 goat anti-rabbit IgG
(1: 1000; Molecular Probes) in 1% NGS in PBS. Sections were rinsed six times in PBS
for 5 min and twice in 0.1M phosphate buffer for 10 min. Following these rinses,
sections were mounted on gelatin-coated slides. Sections were mounted with an antifade mounting media (ProLong; Molecular Probes), coverslipped, and sealed with nail
polish. As an internal control, additional sections were processed as described above;
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however, primary antibodies were omitted from the procedure. Images were captured
using a confocal microscope (Leica TCS-SP2 AOBS; Leica Microsystems,
Bannockburn, IL) with appropriate excitation lasers, detectors, and analysis software.

Zmmunocytochemistry for routine light and electron microscopy

In these protocols, sections were processed with antibodies to either CDl lb/c
(microglia) or CD68 (macrophages) alone or together with antibodies to APP to detect
diffusely injured axons. CDl lblc antibody recognizes the microglia-specific
complement type 3 receptor thus serving as a complementary marker to lectin. In
addition to these approaches, adjacent brain sections were processed with antibodies to
endogenous rat albumin. This was done to assess the potential for injury-induced BBB
disruption. Animals for LM and EM evaluation (n = 3 / injury group, 1 / sham-injury
group, 1 naive) were perfused with 4% paraformaldehyde / 0.1% glutaraldehyde in
Millonig's buffer. Sections were then processed for either CD 1lblc, CD 68, and
albumin or CDl lb/c - APP and CD68 - APP dual immunoreactivity.(Stoneet al.,
2000) Briefly, endogenous peroxidase activity was blocked using 0.3% H202in PBS for
30 min followed by temperature-controlledmodified microwave antigen retrieval
(Stone et al., 1999) and preincubation in 10% NGS with 0.2% Triton X-100. Sections
were incubated overnight with either CDl 1b/c (1:700; mouse anti-rat CDl 1b/c; BD
Pharmingen, San Diego, CA) or CD68 (1:700) primary antibody. Sections were then
incubated for 1 hr with biotinylated rat-absorbed goat anti-mouse IgG (1:200 Vector,
Burlington, CA) secondary antibody. Select sections for dual-labeling underwent
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additional processing beginning with preincubation in 10% NGS followed by Cterminus specific APP (1: 1000) primary antibody. At this time, sections for single-label
albumin (1:40,000; rabbit anti-rat albumin antiserum; Bethyl Laboratories,
Montgomery, TX) primary antibodies were also processed in 1% NGS in PBS. Sections
processed with APP or albumin antibodies were then incubated for 1 hr with
biotinylated rat-absorbed goat anti-rabbit IgG (1:200 Vector). All sections were then
visualized via incubation in avidin-horseradish peroxidase complex (Vectastain ABC
Standard Elite Kit; Vector) for 1 hr followed by 0.05% diaminobenzidine (DAB),
0.01% H202,and 0.3% imidazole in O.1M phosphate buffer for 10-20 min. The
common chromogen DAB was used for convenience in that structural correlates of
BBB disruption, axonal injury, and microglial I macrophage change were so discreet as
to create no problem in morphological recognition. Sections processed for either CD
1lblc, CD 68, or albumin as well as select sections processed for CD 1lblc - APP and
CD 68 - APP were mounted on gelatin-coated slides, dehydrated, and coverslipped for
routine LM evaluation while the remaining dual-labeled sections underwent continued
processing for EM. As an internal control, additional sections were processed as
described above; however, primary antibodies were omitted from the procedure. LM
images were captured using an Eclipse 800 microscope (Nikon, Tokyo, Japan) fitted
with a Spot-RT digital camera (Diagnostic Instruments, Sterling Heights, MI).
As noted, dual-labeled sections were processed for EM to ascertain
ultrastructural detail relevant to those changes observed via confocal microscopy.
Following antibody processing, the tissue was osmicated in 1% Os04 and then placed in
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graded alcohols and propylene oxide prior to placement in epoxy resin (Ted Pella,
Redding, CA). Sections were then embedded between plastic slides (Thomas Scientific
Co., Swedesboro, NJ), placed in 55OC oven for 3 days, and then scanned to identify
immunoreactive axonal swellings along with microglia I macrophages. Once identified,
these sites were removed, mounted onto plastic studs, and thick sectioned to the depth
of interest using an ultramicrotome (Leica Ultracut R; Wien, Austria). Semithin sections
(1 pm) stained with 1% Toluidine Blue were again screened for evidence of microglial

activation I macrophage localization with TAI. Serial thin sections (70 nm) were then
cut, picked up onto Formvar-coated slotted grids, and stained in 5% uranyl acetate in
50% methanol for 2 min. and 0.5% lead citrate for I min. Images were captured using a
JOEL 1230 electron microscope using a digital camera (Gatan Digital Micrograph,
Pleasanton, CA).

Results
Naive and Sham-injury - Generalfindings and cellular phenotypes
Macroscopically, sham-injured brains showed no evidence of compression,
contusion, or tissue loss. Tissue sections from naive and sham-injured animals
processed for the visualization of APP and examined by light and confocal microscopy
demonstrated limited background staining with the finding of only isolated
immunoreactive somata. There was no evidence, however, of immunoreactive axons or
swellings adjacent to these somata. Markers of microglia (isolectin B4 and CD 1lblc)
demonstrated conventional resting morphology in that microglia exhibited a small cell
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body with highly ramified processes and were distributed evenly throughout the brain
parenchyma (Fig. 3-2A-C). Sections processed for macrophage immunoreactivity (CD
68) demonstrated a limited number of immunoreactive cells primarily in perivascular
locations (Fig. 3-3A-C). Sham-injured tissue sections processed for the visualization of
albumin revealed only limited immunoreactivity underlying the craniotomy site
together with minimal imrnunoreactivity within the subcortical white matter. Otherwise,
albumin immunoreactivity was confined to the vascular lumen and walls with no
extension into the brain parenchyma (Fig. 3-4A).

Diffuse Injury - Light, electron, and confocal microscopicfindings
Injured brains shared identical macroscopic features with sham-injured brains
with the exception of limited subarachnoid hemorrhage found under the craniotomy
site. Additionally, scattered petechial hemorrhages could be observed within the corpus
callosum.

APP Zmmunoreactivity

APP immunoreactive axonal swellings, a signature of diffuse TBI, were visible
at 6 and 24 hrs post-injury. Consistent with previous descriptions of experimental DBI
in this animal model as outlined in Chapter 2, axonal swellings were most prominent
within the mediodorsal neocortex, hippocampal dentate gyms, and dorsolateral
thalamus with additional swellings found scattered in the corpus callosum, subcortical
white matter, and brainstem (Singleton et al., 2002). Select swellings could be traced

Fig. 3-2. Spatiotemporal evaluation of microglia activation within DBI loci. Using
antibodies to CD 1 1blc, that recognize the microglia-specific complement type 3
receptor, microglial morphology was visualized within loci known to elicit DBImediated TAI. Note that sham-injury (A-C) reveals microglia with resting morphology
characterized by a small cell body with highly ramified processes. Between 6 - 24 hrs
post-injury (D-F), most microglia demonstrate the initial signs of activation including
increased cell body size, with a concomitant reduction in process ramification leading to
an increased immunoreactive ameboid-like morphology. However, others maintain a
resting phenotype. Within DBI loci, activated morphology predominates and persists at
7 (G-I), 14 (J-L), and 28 (M-0) d post-injury. (scale bar = 100 pm)
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Fig. 3-3. Spatiotemporal evaluation of macrophage localization within DBI loci. Similar
to microglial evaluation, antibodies to CD 68, that recognize a macrophage-specific cell
surface marker, were used to visualize macrophages within loci known to elicit DBImediated TAI. Sham-injury (A-C) reveals limited numbers of immunoreactive cells
primarily in perivascular locales. Between 6 - 24 hrs post-injury, parenchymal
macrophage immunoreactivity can be observed within the neocortex (D) and
hippocampus (E) with minimal thalamic (F) involvement. However, note that by 7 d
post-injury, all three regions (G-I) demonstrate robust macrophage immunoreactivity
which persists at 14 (J-L) and 28 (M-0) d post-injury. (scale bar = 100 pm)
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Fig. 3-4. These low-magnification brain microphotographs illustrate the spatiotemporal
course of albumin immunoreactivity following DBI. Note that with sham-injury,
albumin is confined to the vascular walls and lumen with limited imrnunoreactivity
observed in the subcortical white matter. However, at 6 hrs post-injury, diffuse albumin
immunoreactivity is observed throughout the interstitium of the brain. By 24 hrs postinjury, scattered immunoreactivity persists within neocortical and hippocampal
parenchyma while the thalamic parenchyma now reveals limited immunoreactivity. By
7 d post-injury, only minimal albumin irnmunoreactivity is present. At all post-injury
time points, there was no evidence of contusion, hemorrhage, or overt tissue necrosis.
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back to their somata of origin while others were found in isolation. Focal axonal
swellings demonstrated no distal immunoreactivity consistent with axonal
disconnection that has been previously characterized in Chapter 2. By 7 d post-injury,
these immunoreactive axonal swellings were no longer visible, again consistent with
previous observations (Singleton et al., 2002).

Albumin Immunoreactivity as a Marker of BBB Alteration

At 6 hrs post-injury, endogenous albumin immunoreactivity could be identified
diffusely distributed throughout the interstices of the neocortex, hippocampus, and
thalamus. This blood-brain disruption to the normally intravascularly confined serum
albumin occurred without evidence of overt contusion, hemorrhage, or tissue disruption
(Fig. 3-4B). By 24 - 48 hrs post-injury, scattered albumin immunoreactivity persisted
within the interstices of the neocortex and hippocampus while the thalamus now
revealed limited immunoreactivity again confined to the extracellular compartment
(Fig. 3-4C). By 7 d post-injury, only minimal albumin immunoreactivity was evident
with the tissue now appearing reminiscent of that obtained from sham-injured animals
(Fig. 3-4D).

Microglia / Macrophage Responses to DBI

Having evaluated the 6 and 24 h as well as 2 d post-injury time points,
observations from these tissue sections revealed comparable findings. These findings,
however, differed significantly from findings observed between 7 - 28 d post-injury.
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Therefore, observations are grouped as post-acute (6 - 48 h post-injury) and longerterm (7 - 28 d post-injury) to provide clarity and to highlight responses within these
post-injury time frames.

Post-acute Neuroinflammatory Responses
At 6 - 24 hrs post-injury, LM and confocal evaluation revealed scattered
irnrnunoreactive microglia within the mediodorsal neocortex, hippocampal dentate
gyms, and dorsolateral thalamus that maintained highly ramified processes consistent
with a resting phenotype. Other scattered microglia demonstrated reduced
immunoreactivity within their processes together with rounding of their cell bodies, all
of which were suggestive of the initial stages of activation (Fig. 3-2D-F). Microglia
found scattered among diffusely injured axons did not show any consistent spatial
relationship to the axonal swellings, their proximal axonal shafts, or their downstream
disconnected axonal segments that now revealed early anterograde change. In contrast
to those microglia found within these diffusely injured loci, microglia within the
adjoining parenchyma wherein no axonal swellings could be found, maintained a
resting morphology.
At the EM level, microglia were identified via the presence of an electron-dense
CD 1lblc reaction product that outlined their cell membranes. The resting and activated
microglial ultrastructural features were similar although the resting cells displayed
highly ramified appendages, while activated cells revealed enlarged, amoeboid-like cell
membranes. The microglia contained a prominent, round nucleus with heterogeneous
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chromatin clumps beneath the nuclear envelope. Their cytoplasm revealed granular
endoplasmic reticulum with long, narrow cisternae extending through the cytoplasm.
Mitochondria together with electron dense laminar bodies as well as inclusion bodies
characteristic of lipofuscin were also distributed throughout the cytoplasm. Despite
axonal injury, no specific microglia - axonal associations could be discerned within the
above described loci. Activated microglia did not directly approximate either the axonal
swellings or their proximal / distal axonal segments (Fig. 3-5).
In the 6 - 24 h time frame, immunoreactive tissue macrophages could also be
identified by LM and confocal microscopy. These cells were localized to the neocortical
and hippocampal parenchyma at 6 hrs post-injury without thalamic involvement (Fig 33D-E). The adjoining, non-TAI containing brain regions revealed no parenchymal
macrophage immunoreactivity. In all cases, macrophage morphology was similar to that
observed in sham-injured tissue. Within the neocortex, the macrophages displayed a
graded parenchymal distribution; heavier macrophage concentrations occurred in the
superficial cortex abutting the subarachnoid space, with increasingly reduced
concentrations seen in the deeper cortical layers. In contrast, the hippocampal
macrophage distribution was more heterogeneous in that cells were found evenly
scattered throughout the hippocampal region. While diffusely distributed within these
loci, macrophages were not associated with any component of axonal injury. EM
evaluation of macrophage ultrastructure, via CD 68 electron-dense reaction product
membrane deposition, was comparable to that of activated microglia and confirmed no
axonal associations.

Fig. 3-5. Electron micrograph of the dorsolateral thalamus at 6 - 24 hrs post-injury.
Dual-label antibody processing for microglia (CD 1lblc) and TAI (APP) was employed
although both appear electron dense at the EM level. Note that electron-dense reaction
product and distinct ultrastructural morphology allow for identification of both the
microglia and reactive axons. Activated microglial ultrastructure (single asterisk)
demonstrates an ameboid-like membrane, ringed with an electron-dense CD 1lblc
reaction product. Also note the prominent round nucleus with heterogeneous chromatin
clumps beneath the nuclear envelope and granular endoplasmic reticulum with long,
narrow cisternae extending through the cytoplasm. Electron-dense laminar bodies as
well as inclusion bodies characteristic of lipofuscin can also be seen distributed
throughout the cytoplasm. TAI (double asterisk) is characterized by axonal swellings
containing electron-dense APP reaction product, organelle pooling, neurofilament
misalignment, and microtubule loss. Additionally, more advanced axonal pathology
(arrow) is found within this field. In this image, the microglia approximates the axonal
swelling yet does not directly engage it, confirming LM and confocal impressions. Note
that microglia are often separated from sites of axonal injury by glial swellings. (scale
bar = 2 pm)

Figure 3-5
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By 24 - 48 hrs post-injury, microglial immunoreactivity within the above described loci
again revealed resting and activated phenotypes while microglia within adjoining, nonTAI containing parenchyma still maintained a resting morphology.
Within the brain sites revealing diffuse TAI, activated microglia appeared more
numerous than previously seen. The activated microglia demonstrated reduced branch
ramification and more intense immunoreactive amoeboid-like morphology. Despite
enhanced activation, there was still no evidence of direct microglial engagement of the
traumatically injured axons, similar to observations made at the earlier post-injury time
point (Fig. 3-6). While activated microglial morphology now predominated within
injured loci, additional microglia adopted a lengthened morphology. This suggested a
redistribution of their processes consistent with potential migration (Fig. 3-7). EM
evaluation revealed activated microglia within injured loci scattered among sites of
axonal injury characterized by electron-dense APP reaction product, organelle pooling,
neurofilament misalignment, and microtubule loss (Fig. 3-5). However, there was no
evidence of microglial projections or engulfment of these sites of injury and reactive
change. In fact, glial swellings often separated microglia from sites of axonal injury.

LM and confocal microscopy also revealed macrophage immunoreactivity that persisted
within neocortical and hippocampal parenchyma, with scattered thalamic
immunoreactivity now recognized at 24 - 48 hrs post-injury (Fig. 3-3F). While
numerous macrophages were found in isolation scattered throughout these brain loci,
occasional macrophages could now be recognized approximating the somata of
perisomatically axotomized neurons, particularly those within the neocortex (Fig. 3-8).

Fig. 3-6. This figure is a confocal micrograph of the dorsolateral thalamus at 24 hrs
post-injury following double-label antibody processing for microglia and TAI.
Microglia (isolectin B4; green - double arrowheads) and TAI (APP; red - single
arrowheads) were identified to assess potential interactions between inflammatory cells
and TAI, a key characteristic of DBI. Note that while microglial activation and DBImediated TAI pathogenesis share a spatiotemporal relationship, there is no evidence of
direct microglial association with any component of injured axons at this post-injury
time point. Although activated rnicroglia can be seen scattered among traumatically
injured axons, no direct engagement of these fibers occurs. (scale bar = 20 pm; Note:
Isolectin also binds blood vessels (BV).)
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Figure 3-6

Fig. 3-7. This figure reveals a confocal micrograph of microglia processed with Alexa488 conjugated isolectin B4 antibodies at 24 hrs post-injury. While most microglia
within DBI loci adopt activated phenotypes (arrows), select cells now reduce their
ramified processes and redistribute them in an elongated fashion (arrowheads). The
generation of apparent forward and trailing processes suggests potential migration
although fixation of tissue prior to immunocytological processing made definitive
evaluation of this migration difficult. (scale bar = 20 pm)

Figure 3-7
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Macrophages were observed encompassing significant portions of the neuronal soma,
with many now taking on a rounded or semi-circular shape to closely follow the
neuron's contour. EM evaluation revealed the macrophages' close adherence to the
neuronal somatic membrane (Fig. 3-9). With the approximation of the somatic
membrane, there was no evidence of somatic engulfment or phagocytic activity; yet,
this macrophage investment was associated with somatic bouton disruption (Fig. 3-9A)
and loss (Fig. 3-9B).

Longer-term Neuroinflammatory Responses
By 7 d post-injury, LM and confocal microscopy revealed enhanced microglial I
macrophage immunoreactivity within the diffusely injured loci (Figs. 3-2G-I and 3-3GI) with increased macrophage immunoreactivity recognized within the thalamus (Fig. 3-

31). Once again, only resting microglial morphology and sparse macrophage
immunoreactivity could be observed within adjoining, non-TAI containing regions. LM
evaluation of TAI-containing loci revealed no evidence of widespread necrotic neuronal
cell death or tissue necrosis similar to that typically described following focal brain
pathology. Similarly, no related microglial or macrophage clustering was observed in
relation to these diffusely injured loci and their damaged axonal segments despite
continued microglial activation and the presence of macrophages.
At 14 - 28 d post-injury, activated microglial I macrophage immunoreactivity
persisted within the previously identified neocortical, hippocampal, and thalamic loci
(Figs. 3-25-0 and 3-35-0). Limited activated microglia / macrophages were now

Fig. 3-9. These electron micrographs of DBI loci at 24 hrs post-injury were processed
following dual-labeling of macrophages (CD 68) and TAI (APP) to identify these
components using methodology similar to microglia - TAI evaluation. In these
examples, macrophages approximate somata within DBI-mediated TAI loci. While
select macrophages (asterisk) maintain their conventional rounded morphology (A),
other microglia adopt semi-circular morphology to approximate a significant portion of
the somatic membrane (B). Macrophage ultrastructure is similar to that of activated
microglia while neuronal somatic ultrastructure (Nu) reveals no significant pathological
change. Note that this macrophage investment is associated with apparent bouton
disruption (box with enlargement in panel A). Other examples reveal somatic
membranes devoid of bouton ultrastructure (B). (scale bar = 1 pm; enlargement scale
bar = 250 nm)
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identified within tissue immediately adjacent to these loci with more remote sites
continuing to maintain resting microglial morphology and sparse macrophage
immunoreactivity. In contrast, enhanced macrophage immunoreactivity was recognized

along the dentate gyms granule cell layer (Fig. 3-3N). While not observed at earlier
time points, limited activated microglial aggregations were now seen, particularly
within the thalamus at 28 d post-injury (Fig. 3-10). However, these aggregations,
previously described following focal pathology, were not numerous within injured loci.
Comparable to LM observations from earlier time points, there was no evidence of
widespread necrotic cell death or tissue necrosis.
While evaluations of immune cell - axonal interactions at earlier time points did
not reveal specific spatial associations, EM evaluation of activated microglia 1
macrophages at all time points beyond 7 d post-injury revealed consistent immune cell
interactions with axonal injury foci. These interactions included immune cell
projections and/or cell body contact with damaged axons or their related debris as well
as phagocytosis, inferred from myelin debris observed within the cytoplasm of
immunoreactive cells (Fig. 3-1 1). Similar to LM findings within this time frame,
widespread necrotic cell death or tissue necrosis was not observed. In a related finding,
macrophages localized to neuronal somatic membranes still did not show evidence of
somatic engulfment or phagocytic activity.

Fig. 3-10. This micrograph reveals the atypical finding of microglial aggregations
within the dorsolateral thalamus at 28 d post-injury. Using antibodies to CD 1lblc, the
majority of activated microglia within DBI loci do not cluster (arrow). However, limited
findings of grouped activated microglia are observed (encircled). This finding is more
characteristically observed during histological examination following focal brain injury.
(scale bar = 100 pm)
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Fig. 3-1 1. These electron micrographs of DBI loci at 7 - 28 d post-injury identified
microglia using electron-dense CD 1lb/c reaction product deposition on the cell
membrane. Although microglia did not engage damaged axons at more acute postinjury time points, these micrographs reveal activated microglial recognition of axonal
debris (arrows) by projection formation (A) and direct cell body contact (B).
Phagocytosis is inferred from myelin debris observed within the immune cell cytoplasm
(box in panel B). Neither widespread immune cell clustering nor somatic engulfment,
each suggestive of neuronal cell death, are observed at this time interval. (scale bar = 2

Figure 3-11

Discussion
The inflammatory response to TBI represents a coordinated effort by resident
microglia and peripheral blood leukocytes to protect the brain following trauma.
Although this protective function is essential to preserving viable tissue and promoting
recovery, recent evidence suggests that the neuroinflammation itself may also be
responsible for the initiation of delayed I secondary injury cascades (MorgantiKossmann et al., 2002). Accordingly, a fully comprehensive examination of TBImediated neuroinflammation is essential for designing rational approaches to
therapeutically modulate pathological aspects of this response. With this rationale in
mind, this manuscript provided a spatiotemporal characterization of microglia I
macrophage interactions following DBI as assessed by light, confocal, and electron
microscopic evaluation of microglial activation and macrophage localization within the
diffusely injured brain revealing TAI in the absence of focal contusion or hemorrhage.
As intrinsic primary immune effecter cells of the brain parenchyma, microglia
are the first line of defense following traumatic insult (Kreutzberg, 1996). Focal TBI
often results in primary axotomy together with other destructive and ischemic neuronal
changes while diffuse TBI results primarily in DAI, known as TAI in the experimental
setting, that leads to delayed or secondary axotomy without concomitant tissue
disruption. Previous studies documenting focal TBI-mediated microglial activation have
demonstrated a robust response to primary axotomy generated via either ex vivo slice
preparation (Dailey and Waite, 1999; Stence et al., 2001; Grossmann et al., 2002), in

vivo stab wounding (Carbonell et al., 2005), or in vivo medial forebrain bundle
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transection (Cho et al., 2006), all of which involve direct tissue transection. In
comparison, microglial responses to diffuse TBI and its associated axotomy have
received little attention. Previous studies of rodent and human microglial activation
following TBI have demonstrated no specific associations between microglia and
injured axons (Oehmichen et al., 1999; Csuka et al., 2000) despite evidence for
traumatically induced microglia - neuronal interactions (Aldskogius and Kozlova,
1998; Bruce-Keller, 1999). In the current communication, microglial activation shared a
spatiotemporal relationship with TAI within diffusely injured brain loci that included
the mediodorsal neocortex, hippocampal dentate gyrus, and dorsolateral thalamus.
However, the activated microglia did not show, via confocal or electron microscopy,
any specific andlor consistent relationship to sites of axonal injury in the acute stages
following injury. The observed activation persisted until at least 28 d post-injury and in
this sense, was consistent with time courses of microglial activation following brain and
spinal cord trauma (Aihara et al., 1995; Popovich et al., 1997;Stence et al., 2001;
Rodriguez-Paez et al., 2005). However, in the current study, the immune cell
recognition of axonal debris at the EM level occurred only between 7 - 28 d post-injury.
In contrast to this microglial activation, other microglia within adjoining, non-TAI
containing parenchyma maintained a resting morphology. This data suggests an early
generalized microglial response to DBI followed by a delayed targeted response to its
attendant axotomy, with the microglia in non-TAI containing regions remaining
quiescent.
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This initial microglial activation without specific axonal targeting suggests that
in DBI, microglia are activated within their local microenvironments yet remain
stationary despite DBI-mediated axotomy. A recent study by Nimmerjahn and
colleagues (2005) supports this observation via documentation that resting microglia,
traditionally believed to be dormant during times of homeostasis, actively survey their
local microenvironment using projections from ramified processes, sending longer
projections to areas of local tissue damage associated with overt tissue disruption and
BBB compromise while their cell bodies remain stationary (Nimmerjahn et al., 2005). It
seems reasonable that microglia can adopt activated phenotypes and continuously
monitor local parenchymal domains yet remain non-migratory, failing to send
projections to sites of axonal injury. This finding with diffuse injury may reflect the
lack of appropriate chemotactic stimuli that are typically generated following focal
brain injury wherein overt BBB and/or tissue disruption occurs (Chen et al., 2003;
Carbonell et al., 2005). Further, moving on the premise that rapid axolemmal closure
associated with perisomatic TAI and consequent axotomy, as outlined in Chapter 2,
most likely preclude the unregulated release of intra-axonal components into the
surrounding parenchyma, this also suggests insufficient chemotactic molecule
concentrations to stimulate migration and/or projection formation. In the current study,
the subtle interstitial albumin immunoreactivity at 6 hrs post-injury, combined with the
absence of overt neuronall tissue damage, supports a scenario in which blood-borne
signaling molecule concentrations may be sufficient to achieve microglial activation yet
insufficient to stimulate migration and/or projection formation, at least in the early
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stages following injury. Our finding of microglia within adjoining, non-TAI containing
regions that are also exposed to albumin yet fail to demonstrate an activated phenotype
suggests a specific role for TAI pathogenesis in microglial activation. To date, the
molecular mechanisms dictating traumatically induced microglial activation and
motility are poorly understood. However, studies are presently beginning to elucidate
the specific molecules and receptors, including ATP and cysteine-cysteine chemokine
receptor 5, involved in microglial activation and chemotaxis following trauma (Polazzi
and Contestabile, 2002; Carbonell et al., 2005; Davalos et al., 2005).
Although microglia were not recruited to sites of TAI within the acute phases
following injury, motile morphology was observed in select cells. Following DBIinduced activation, select microglia became elongated with the suggestion of forward
and trailing processes. Although the majority of activated microglia remained diffusely
distributed throughout injured loci, microglial motility is consistent with infrequent
observations of microglial aggregations at later time points post-injury. Further
assessment of microglial motility was confounded by the acute upregulation of
microglial APP following activation (Banati et al., 1993), which made LM distinction
between microglial processes and reactive axons difficult in certain instances, and by
the inability of APP immunoreactivity to recognize TAI at longer post-injury time
points (Singleton et al., 2002). The development of novel TAI markers allowing for
long-term labeling of injured axons will allow for more definitive conclusions
concerning rnicroglial motility to sites of diffuse axonal pathology.
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In addition to microglial activation within injured loci, macrophages were also
found within neocortical and hippocampal parenchyma at 6 hrs post-injury, with their
recognition in the thalamus by 24 hrs. In all of these loci, the macrophages persisted
until at least 28 d post-injury. Csuka and colleagues (2000), using an impactacceleration model of DBI that did not document immune cell interactions with sites of
axonal injury, described macrophage immunoreactivity within the meninges, basal
subarachnoid space, Virchow-Robin's space, ventricular choroid plexus, subventricular
zone, and perivascular locales suggesting minimal post-injury parenchymal entry
(Csuka et al., 2000). In contrast, in the current study macrophages were distributed
within the parenchyma of the diffusely injured loci. For example, macrophages were
observed within superficial and deep layers of the neocortex, a finding consistent with
previous observations of macrophage infiltration following lateral fluid percussioninduced mild brain injury (Aihara et al., 1995). Parenchymal macrophage
immunoreactivity at relatively early post-injury time points is strongly suggestive of
macrophages originating from the peripheral vasculature although differentiation of
resident microglia cannot be definitively excluded. Macrophages found within the
parenchyma of diffusely injured loci without overt contusion or related hemorrhage
suggests the potential for coordinated movement through an injury-induced, transiently
perturbed BBB (Hartl et al., 1997a; Hartl et al., 1997b) as suggested by post-injury
interstitial albumin immunoreactivity (Cortez et al., 1989; Schmidt and Grady, 1993;
Barzo et al., 1996; Baskaya et al., 1997). Although the precise origins of DBI-mediated
parenchymal macrophages cannot be definitively determined from this study, these
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findings illustrate the importance of using multiple DBI models in future studies to
assess leukocyte localization following trauma. Studies using pre-injury labeled
peripheral blood monocytes andfor bone marrow chimeric animals may provide insight
into the relative contribution and distribution of exogenous versus endogenous
macrophage populations following DBI (Popovich and Hickey, 2001; Ladeby et al.,
2005).
While numerous macrophages were observed in isolation, other macrophages
approximated somata of perisomatically axotomized neurons, particularly within the
neocortex by 24 hrs post-injury. EM evaluation of macrophage - soma interactions
revealed macrophages encompassing large components of the somatic membrane,
having adopted rounded or semi-circular morphology to approximate the membrane,
potentially participating in somatic bouton disruption and loss. This association was
reminiscent of the phenomenon in which regenerating neurons undergo inflammatorymediated deafferentation of synaptic terminals which confers an adaptive advantage for
potential synaptic reorganization, known as synaptic stripping (Blinzinger and
Kreutzberg, 1968). Using facial nerve primary axotomy, a model quite dissimilar from
DBI-mediated secondary axotomy, microglia, macrophages, and peripheral leukocytes
all responded to initial neuronal degeneration prior to regeneration. Microglia were
specifically implicated in separating boutons from neuronal cell bodies (Kreutzberg,
1995; Graeber et al., 1998; Raivich et al., 1998). Given the suggestion of somatic
reorganization and repair following DBI-mediated axotomy (Singleton et al., 2002),
macrophage - somatic associations seem plausible. Although microglia were not
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recognized approximating somatic membranes following DBI, neuronal mechanisms
responsible for immune cell recruitment following trauma may be different given the
primary versus secondary nature of axotomy. Perhaps mechanisms stimulated by
primary axotomy favor microglial recruitment whereas mechanisms following
secondary axotomy preferentially recruit macrophages. However, it is also possible that
these macrophages may have differentiated from perineuronal microglia that
approximate somata under non-pathologic conditions (Peters et al., 1991).
At this time, it is unclear whether these macrophages originated from the
peripheral vasculature or differentiated from prepositioned microglia. Nonetheless,
close approximation of the macrophage to the somatic membrane is strongly suggestive
of immune cell - neuron crosstalk mechanisms. To date, several molecules released by
neurons following trauma have been implicated in immune cell activation and
recruitment (Polazzi and Contestabile, 2002). The severity of neuronal injury may
dictate the nature of these signals with reversible injury leading to immune cellmediated trophic support while irreversible injury may enhance immune cell-derived
neurotoxic-mediated cell death (Streit et al., 1999). Given the suggestion of neuronal
somatic reorganization and repair as well as the absence of widespread necrotic
neuronal cell death following moderate DBI (Singleton et al., 2002), these observations
support potential immune cell - neuron trophic interactions. Studies in our laboratory
are currently examining the long-term fate of neurons to provide additional insight into
neuronal signaling responses and outcomes following DBI.
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Following TBI, immune cell activation is driven primarily by neuronal
degeneration (Kreutzberg, 1996; Streit, 2000). However, the lack of DBI-mediated cell
death in the cFPI model (Singleton et al., 2002) suggests that ongoing microglial /
macrophage activation (up to 28 d in the current communication) may be supported by
DBI-mediated secondary pathologies such as cellular membrane perturbation andor
Wallerian degeneration leading to synaptic disruption. Membrane perturbation may
stimulate cytokine / chemokine release by injured neurons andor surrounding glia
(Aloisi, 2001; Hansson and Ronnback, 2003). The post-injury release of these
molecules may then contribute to sustained immune cell activation long after the initial
injury stimulus has dissipated (Bajetto et al., 2002; Babcock et al., 2003; Gentleman et
al., 2004; Kim and de Vellis, 2005). Similarly, Wallerian change and related
deafferentation are known stimuli for immune cell activation. Given the rapid Wallerian
degeneration that takes place following DBI-mediated perisomatic TAI outlined in
Chapter 2, the presence of axonal breakdown products may also contribute to prolonged
activation. Studies by Dong and colleagues, using a dissimilar entorhinal cortex lesion
paradigm involving transection of afferent fibers to the hippocampus, noted microglial
activation within denervated portions of the hippocampus as late as fifteen days postinjury (Dong et al., 2004; Dong et al., 2005; Dong et al., 2006). In the current
communication, sustained macrophage activation was observed along the hippocampal
dentate gyms granule cell layer, corresponding to sites of synaptic input and consistent
with previous findings following experimental DBI (Carbonell and Grady, 1999). As
such, deafferentation may trigger supplemental neuronal injury response mechanisms

133
that continue to signal immune cells originally activated by stimulatory molecules
released during the initial traumatic episode (Aldskogius et al., 1999; Bruce-Keller,
1999). Although precise identification of secondary injury mechanisms leading to
prolonged immune cell activation remains elusive, persistent post-traumatic microglial /
macrophage activation has implications for understanding neuronal plasticity and
potential recovery following trauma (Banati, 2002; Banati, 2003).
The current communication's findings may also have implications for
neuropathological evaluation of TBI. Microglial clustering in post-mortem histological
neuropathology is currently used as a diagnostic indicator of TBI-related pathobiology
that includes axotomy (Adams et al., 1989). These clusters or nodules have been
documented with survival times of at least seven weeks post-injury (Povlishock and
Becker, 1985) with more recent evidence of clustering between ten and fifteen days
post-injury (Geddes et al., 1997; Oehmichen et al., 1999). In the current
communication, only isolated microglial aggregations occurred at 28 d post-injury.
Further, LM morphology of these aggregations revealed dissimilarities between these
aggregations and those clusters / nodules involved in microglial-mediated
neuronophagia. Given the absence of focal pathology within DBI-mediated TAIcontaining loci, previous descriptions of microglial clusters may be indicative of focal
pathology, in which necrotic cell death andor hemorrhagic tissue damage triggers
microglial recruitment via chemotactic signaling molecules. In contrast, the lack of
neuronal cell death and the absence of overt tissue damage associated with moderate
DBI may explain why microglial clustering does not take place, at least within the time
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frame of the current communication. Our findings suggest that histopathological and
forensic identifications of TBI that rely on surrogate markers of neuronal injury, such as
microglial clustering, may overlook and thus underestimate more subtle forms of
diffuse pathology. Accordingly, TBI histopathological evaluation may be expanded to
address microglial / macrophage immunoreactive findings indicative of DBI, namely
early and persistent microglial activation and macrophage localization within diffuse
brain regions without requisite cluster / nodule formation.

Chapter 4

GENERAL DISCUSSION

The purpose of this section is not to reiterate material provided in the previous
discussions related to Chapters 2 and 3. Rather the goal here is to explore general
concepts pertinent to the findings of this dissertation as a whole. A brief synopsis is
provided to review the most prominent findings related to the study of DBI-mediated
perisomatic TAI and the related neuroinflammatory response thereby providing a
foundation for future investigation.

SYNOPSIS
To complete this dissertation on TAI pathogenesis within the perisomatic
domain and the related microglia 1 macrophage responses to DBI, a midlinelcentral FPI
model of moderate severity was utilized. This model provided a reliable and
reproducible axonal pathology that was localized to a specific distance from the soma of
origin and was found within specific anatomical loci. Additionally, diffuse TAI was
observed without evidence of overt focal contusions andlor hemorrhagic-mediated
tissue damage. Using immunohistochemical techniques, antibodies to the anterogradely
transported P-APP were used to mark the site of focally impaired axonal transport

following injury, a key characteristic of TAI pathology. The spatiotemporal
progression, ultrastructural pathology, and permeability alteration of this injury site as
well as findings related to the soma and proximal / distal segments were characterized
in Chapter 2 while microglia / macrophage responses to DBI and its associated
pathology were explored in Chapter 3.
As detailed in Chapter 2, TAI within the perisomatic domain resulted in an ultrarapid secondary axotomy and Wallerian degeneration. Investigation of perisomatic TAI
was prompted by an initial study of the related somatic response to secondary
perisomatic axotomy. Despite axonal disconnection within 4.0 - 60 pm of the sustaining
soma, DBI-mediated traumatically injured neurons did not progress to rapid cell death
(Singleton et al., 2002). This observation, which contrasted previous studies of neuronal
death following axonal transection within a similar distance from the soma, suggested
that the manner in which perisomatic axotomy took place afforded some form of
somatic protection following axonal trauma. It was speculated that the time frame over
which secondary axotomy evolved (i.e. within several hours following DBI) was an
important factor. However, as reported in this dissertation, as early as 15 - 30 min
following DBI, perisomatically injured axons had lost continuity with their downstream
segments while the related soma and proximal axonal segment showed no overt signs of
pathology. Ultrastructural analysis of the site of axonal injury revealed neurofilament
disorganization, microtubule loss, mitochondria1 pathology, and pooling of intra-axonal
organelles. These observations were comparable to those documented in previous
studies of TAI within long tract axons of the brainstem (Pettus et al., 1994; Pettus and
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Povlishock, 1996). The related distal axonal segment ultrastructure was persevered at
this time point; however, by 60 - 180 min post-injury, the initial stages of Wallerian
degeneration were apparent. The site of axonal swelling and disconnection was
independent of overt alterations in axolemmal permeability. Taken together, these
observations suggest that maintenance of axonal integrity rather than speed of
disconnection is more important in providing somatic protection following TAI.
The neuroinflammatory response to DBI and its related pathological sequelae as
outlined in Chapter 2 was the focus of Chapter 3. The immune response to TBI involves
both resident microglia as well as peripheral blood monocytes recruited from the
surrounding vasculature. Microglia I macrophage responses to DBI were characterized
using antibodies to immune cell surface proteins in conjunction with TAI labeling to
visualize diffusely injured brain loci uncomplicated by focal pathology. Given the
rapidity of TAI pathology, it was assumed that immune cells would rapidly target sites
of axotomy. At 6 - 24 hrs following DBI, scattered LM microglial activation was
observed within injured loci while other scattered microglia within adjoining non-TAI
containing regions maintained a resting phenotype. DBI-mediated activated microglia
phenotype included a rounded cell body, decreased process ramification, and enhanced
immunoreactivity that persisted until at least 28 d post-injury. Comprehensive EM
evaluation did not reveal specific microglia - neuron associations within the first seven
days post-injury, rather simply an initial generalized activation response to trauma.
Microglial-mediated phagocytosis of axonal debris followed at subsequent post-injury
time points without evidence of clustering I nodule formation. Macrophages were also
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observed within injured neocortical and hippocampal loci at 6 hrs post-injury with
recognition in the thalamus at 24 hrs post-injury, again with little to no
immunoreactivity within adjoining non-TAI containing regions. These cells appeared
within the parenchyma despite no evidence of focal contusion, hemorrhage, or tissue
disruption. EM evaluation revealed a spatiotemporal relationship to TAI comparable to
microglial findings. However, select macrophages approximated somata of
perisomatically axotomized neurons within 24 hrs post-injury although their origin from
either peripheral blood monocyte or microglial differentiation could not be definitively
determined. Despite this association, there was no evidence of somatic engulfment or
phagocytic activity. Macrophage immunoreactivity within injured loci persisted at 28 d
post-injury while adjoining regions remained devoid of immunoreactivity. These
findings suggest that neuroinflammatory responses to DBI are distinct from those
related to focal TBI and that TBI histological evaluation that relies on markers such as
microglial clustering may inadvertently overlook and thus underestimate the extent of
DBI-mediated axonal pathology.
INHERENT DIFFICULTIES IN STUDYING DBI-MEDIATED TAI
As the work detailed in this dissertation indicates, TAI in the perisomatic
domain is characterized by ultra-rapid secondary axotomy and Wallerian degeneration
and is accompanied by reactive microglia 1 macrophage responses. To study TAI and its
resultant consequences within the context of DBI, a reliable and reproducible injury
model is necessary. Rodent FPI (Dixon et al., 1987) provides a clinically relevant model
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of human diffuse TBI. Descriptive characterizations of brain pathology generated by the
central and lateral 1parasagittal versions of this model include physiological, metabolic,
and cytological pathology as well as hemorrhagic and related ischemic damage, BBB
disruption, and alterations of behavioral and cognitive outcome measures (McIntosh et
al., 1987; Dixon et al., 1988; Mchtosh et al., 1989; Hicks et al., 1996; Thomas et al.,
2000; Thompson et al., 2005). Focusing on axonal pathology, the nature of DBI is such
that traumatically injured axons are found among other CNS constituents that
demonstrate little or no pathology. Given that midlinelcentral FPI of moderate severity
generates TAI within diffuse brain regions, among other fibers and cells exhibiting no
distinct pathological alterations, and without evidence of overt focal pathology, this
injury model mimics comparable pathologies described in mild to moderate human DBI
(Adams, 1992; Graham, 1996).
Although DBI-mediated TAI can be generated in specific anatomical loci using
FPI, study of its cellular and molecular pathologies is confounded by the nature of this
injury. TAI is found scattered throughout the brain as well as interspersed within normal
CNS constituents making examination of injured axons difficult. Although
identification of microscopic diffuse TAI has been facilitated through the use of
antibodies targeting specific axonal pathological cascades or end-products, isolation of
injured axons for molecular analysis is a daunting task given the likelihood of the
concomitant collection of axons and brain tissue immediately adjacent to the pathology.
In contrast to diffuse injury, the highly concentrated and homogenous nature of focal
brain injury lends itself to a variety of experimental techniques to examine the cellular
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response to injury. In focal injury, an injury nidus may be reliably located and isolated
from related tissue allowing for numerous analyses to study cellular responses.
Despite these inherent limitations, the study of DAI, and its experimental
equivalent TAI, remains an important scientific objective. With DAI as the predominant
mechanism of injury for 40 - 50 percent of TI31 hospital admissions and, as such, a
major contributor to the morbidity and mortality associated with TBI (Meythaler et al.,
2001), continued basic science research into TAI pathobiology is needed to provide
insights into mechanisms of axonal damage and to discern potential targets for
therapeutic treatment options. Thus, translational research between basic science and
clinical arenas is vital; however, the application of basic science knowledge to the
clinical realm must be carefully measured. Inevitably, it is the collective brain response
to diffuse injury that ultimately dictates axonal pathology and the related inflammatory
responses.

MECHANISMS OF ULTRA-RAPID TAI PATHOLOGY
Given the precise anatomical localization of injury as well as the related
secondary axotomy and Wallerian degeneration, DBI-mediated perisomatic TAI
pathology offers a unique opportunity to study axonal injury mechanisms and to explore
pathobiological consequences of neuron - glial cell interactions and neuronal pathway
deafferentation within the context of TBI. As DBI relates to axonal injury mechanisms,
previous studies from our laboratory and others implicate calpain and caspase-mediated
cytoskeletal proteolysis within minutes to hours following TAI (Saatman et al., 1996;
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Buki et al., 1999; Buki et al., 2000; Saatman et al., 2003) with others reporting similar
cytoskeletal pathology within this time frame (Gennarelli et al., 1993; Jafari et al., 1997;
Maxwell and Graham, 1997; Jafari et al., 1998). The spatiotemporal progression of
thalamic perisomatic TAI is comparable to studies of experimental diffuse neuronal
injury using fluid percussion which include thalamic neuronal damage as early as 10
rnin following injury (Dixon et al., 1987; Hicks et al., 1996; Bramlett et al., 1997; Sato
et al., 2001). However, despite the abundance of information regarding TAI
pathogenesis, the precise subcellular mechanisms of perisomatic TAI pathology remain
elusive.
A variety of antibodies to proteolytic proteins and degradation products
implicated in TAI pathobiology have been used to attempt to describe mechanisms of
injury within the perisomatic domain. However, markers of calpain and caspase
activation as well as spectrin proteolytic products have met with little success in this
region (unpublished observations). These same antibodies have been successful in
determining mechanisms of brainstem TAI pathology suggesting that axonal size may
be a factor not only in antibody binding affinity but also in potential mechanisms of
pathology. Large caliber axons found within ascending and descending white matter
tracts of the brainstem offer a larger target for antibody binding than the smaller caliber
axons of the thalamus. Brainstem axons are also myelinated. Given that myelination
confers additional strength to the axon, more severe diffuse injury forces stimulating the
above mentioned mechanisms may be required to generate pathology within this region.
These ideas are contrasted by the unmyelinated initial segment and thinly myelinated
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internodal segment in which perisomatic TAI pathology is observed, perhaps making
these segments preferentially vulnerable to lower magnitude injury forces. As outlined
in Chapter 2, perisomatic injury is localized to the grey - white matter interface, an area
that is selectively vulnerable to shear and tensile forces (Smith et al., 1997; Meythaler et
al., 2001). It is possible that potentially less severe forces are needed to generate
perisomatic TAI and may result in a more rapid initiation of pathological cascades
following injury. Similarly, lack of tracer flooding at the site of perisomatic secondary
axotomy suggests either minimal or no pathological influx of extracellular ions at this
site. Perhaps influx at this site is more insidious and stimulates the afore mentioned
pathological cascades albeit at levels insufficiently recognized by antibody affinity.
Although the acute mechanisms of perisomatic TAI pathogenesis remain
elusive, we continue to evaluate the long-term implications of perisomatic TAI and
related axotomy. Ongoing stereological studies from our laboratory suggest neuronal
somatic shrinkage at 7 d following moderate cFPI without evidence of widespread
neuronal cell death with similar observations out to 28 d post-injury (article in
preparation). While mechanisms for neuronal shrinkage are currently being evaluated,
previous studies of perisomatic TAI indicate that injured neurons are terminal
deoxynucleotidyl transferase-mediated biotinylated dUTP nick end labeling (TUNEL)
negative and demonstrate multiple independent injury phenotypes (Singleton et al.,
2002; Singleton and Povlishock, 2004). Recently, our laboratory has studied DBImediated neuronal mechanoporation (Farkas et a]., 2006). Perhaps non-lethal disruption
of the neuronal membrane leads to ionic dysregulation creating fluid shifts which
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ultimately lead to cellular shrinkage. Taken together, these observations have important
clinical implications for head injured patients in that the initiation of DAI pathology
may take place more rapidly than currently believed.

RAPIDITY OF AXOTOMY
The rapidity at which perisomatically injured neurons undergo secondary
axotomy and consequent Wallerian change is disturbing given the relevance of DAI to
human head injury and therapeutic modalities aimed at prevention 1 attenuation of
axonal damage following TBI. Studies of human DAI suggest secondary axotomy
pathogenesis evolves over approximately 12 hrs (Grady et al., 1993; Christman et al.,
1994; Povlishock and Christman, 1995) while experimental paradigms indicate a more
accelerated time frame, approximately 4 - 6 hrs (Pettus et al., 1994; Pettus and
Povlishock, 1996). However, as outlined in Chapter 2, secondary axotomy following
DBI-mediated perisomatic TAI was observed as early as 15 - 30 min post-injury with
consequent Wallerian degeneration noted soon thereafter. Given that the time delay
between initial trauma and axonal disconnection within the perisomatic domain is
shorter than times observed within previous studies of TAI-mediated secondary
axotomy, study of rapid and therapeutically relevant interventions becomes even more
significant.
The phenomenon of DBI-mediated perisomatic TAI remains novel with only
limited study of this unique pathobiology to date (Singleton et al., 2002; Singleton and
Povlishock, 2004). Although ultra-rapid secondary axotomy, as discussed in Chapter 2,
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was also noted within the neocortex and hippocampus, observations for this dissertation
were confined to thalamic nuclei with the inference that these findings could be
extended to neocortical and hippocampal pathology. However, confirmation of identical
neocortical and hippocampal secondary axotomy pathology requires further
investigation. The clinical relevance of these thalamic studies is supported by
documentation of TBI-mediated thalamic neuronal damage in a variety of patients
whose outcomes range from moderately disabled to vegetative (Anderson et al., 1996;
Adams et al., 2000; Uzan et al., 2003; Maxwell et al., 2004) as well as studies of postinjury cognitive function in humans and experimental animals (Terayama et al., 1991;
Pierce et al., 1998; Ding et al., 2001).
In a related fashion, relatively little information exists concerning anterograde /
Wallerian degeneration following TBI. Studies of CNS Wallerian change come mainly
from spinal cord injury (Becerra et al., 1995; Buss et al., 2004) or from experimental in
vitro transection of dorsal root ganglia (Sievers et al., 2003). Classic descriptions of

Wallerian degeneration in humans suggest a pathology that evolves over months and
persists for years following injury (Strich, 1968; Becerra et al., 1995; Buss et al., 2004)
while experimental models accelerate the time frame for pathological change (Maxwell
et al., 2003). The discovery of a mutant mouse strain with slow Wallerian degeneration
has helped to provide additional insight into this pathological process by allowing for
examination of Wallerian change over longer post-injury time periods (Perry et al.,
1991). A more recent study by Maxwell and colleagues reported ultrastructural findings
of Wallerian change at 24 hrs post-injury using an optic nerve stretch injury model of

TAI (Maxwell et a]., 2003). However, as outlined in Chapter 2, DBI-mediated
Wallerian degeneration within 60 - 180 min post-injury and its relationship to ultrarapid secondary axotomy are unique observations in that the speed at which these
events take place is significantly faster than previously recognized.
The speed of these events has important implications for therapeutic
interventions aimed at attenuation 1 elimination of their pathogenesis. To date,
numerous studies attenuating TAI in animal models have met with limited results in
clinical trials (Narayan et al., 2002). Although TAI pathogenesis is accelerated in
animals relative to the human condition, our findings suggest that despite early
intervention following injury (- 15 min) there will be irreversible axonal damage
leading to neuronal pathway degeneration. Providing complete neuroprotection
following TBI may be an unrealistic expectation; nonetheless, therapeutic intervention
remains an important component of attenuating more vigorous neuronal pathology.
Apparently "uninjured" axons may have a delayed response to trauma given the
progressive increase in injured axon and reactive swelling numbers over time.
Recognition of injured axons with apparent normal morphology remains an important
TBI research objective in that these axons appear amenable to therapeutic intervention
and may be rescued from their impending demise.

NEURONAL SIGNALING MODULATING MICROGLIAL ACTIVITY FOLLOWING
TRAUMATIC BRAIN INJURY
It would seem reasonable and rational that neurons communicate with
surrounding microglia to promote a homeostatic environment during periods of rest

while at the same time possessing the capacity to stimulate microglial activation
following traumatic insult. Several lines of evidence supporting microglia - neuron
crosstalk are provided by both in vivo and in vitro studies (Aldskogius and Kozlova,
1998; Polazzi and Contestabile, 2002). During periods of inactivity, microglia
demonstrate a heterogeneous distribution among different regions of the adult rat brain
(Savchenko et al., 2000). Given observations that microglia within different brain
regions demonstrate slightly differing morphologies, this suggests that microglial
activation may be affected by localization and interactions with various cell types
throughout the brain (Polazzi and Contestabile, 2002). For example, when CD200, a
membrane glycoprotein expressed by neurons and whose receptor is found on
microglia, was absent, microglia showed an activated phenotype and formed aggregates
expressing inflammatory molecules (Hoek et al., 2000). This suggests a neuronal
mechanism of microglial downregulation of immune function. Similarly, when
microglial cultures were exposed to neuron-conditioned media, differentiating neurons
released factor(s) capable of inducing apoptosis of activated, but not unstimulated,
microglia suggesting a neuronal-mediated regulation of microglial activation which
serves as a protective mechanism against an overactive inflammatory response (Polazzi
and Contestabile, 2003).
Evidence also exists for neuronal-mediated mechanisms of microglial activation
following traumatic injury. When neurons die, independent of the specific cause of
death, the microglial reaction is stereotyped and consists of quick transformation into an
activated phenotype (Streit et al., 1999; Streit, 2000). Several studies have documented
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the release of pro-inflammatory agents (e.g. TNF-a, IL- 1, IL-6) and trophic factors by
activated microglia in response to neuronal death (Bartholdi and Schwab, 1997; Toku et
al., 1998; Batchelor et al., 1999; Pearson et al., 1999; Stoll et al., 2002). The scripted
microglial response to neuronal cell death is one of motility to the injury site followed
by alterations in morphology including retraction of processes, proliferation, and
increased membrane expression of surface molecules such as complement type 3
receptor (CR3) and major histocompatibility complex class I1 (MHC Class 11) antigen.
Microglia then differentiate into macrophages only in the presence of extensive
neuronal degeneration (Kreutzberg, 1996). In a related response, microglia are also
capable of recruiting monocytes and lymphocytes from the blood stream (Aloisi, 2001).
Although these findings suggest that microglial activation may aggravate ongoing
inflammatory responses, microglia have also been shown to secrete anti-inflammatory
molecules such as TGF-p and IL-10 (Aloisi, 2001) suggesting a dichotomy of both
microglial-mediated neuropathological and neuroprotective functions. Therefore, the
promotion of neuronal survival or exacerbation of neuronal death may depend primarily
on the nature of the neuronal signals responsible for microglial activation which are
released following trauma (Streit et al., 1999; Polazzi and Contestabile, 2002).
Although cytokines responsible for microglial activation have been recognized,
their mechanisms of action and the long-term consequences for microglial activation
remain poorly understood. Emerging literature on the subject of microglial activation
suggests candidate genes and unique morphological characteristics may also be
responsible. One such gene is microglia response factor (mrf-1) which encodes a
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calcium binding protein that does not appear to play a role in phagocytic activity and is
upregulated following neuronal injury (Tanaka et al., 1998). Given that mrf-1 is not
upregulated by phagocytosis, induction may require cell-cell contact between microglia
and degenerating neurons and/or the release by damaged neurons of signals capable of
altering gene expression (Polazzi and Contestabile, 2002). Similarly, microglial cells
have a unique pattern of potassium channels and the possibility of increased
extracellular potassium levels around injured neurons inducing their activation is
supported by an in vivo spreading depression model of potassium chloride that induced
microglial activation (Gehrmann et al., 1993).
Injured neurons may also regulate microglial activation through coordinated
release or leakage of stimulatory molecules such as ATP (Walz et al., 1993). Several
studies have shown that ATP stimulates microglia to release biologically active
substances such as IL-1P (Sanz and Di Virgilio, 2000), TNF-a (Hide et al., 2000), nitric
oxide (Ohtani et al., 2000), and IL-6 (Shigemoto-Mogami et al., 2001) as well as induce
microglial chemotaxis (Honda et al., 2001). More recent in vivo studies have shown
microglial processes to autonomously converge on focal injury sites induced by laser
ablation with ATP release from damaged tissue implicated as a key mediator of this
response (Davalos et al., 2005; Nimmerjahn et al., 2005). Additionally, matrix
metalloproteinase-3 released by apoptotic neuronal cells has recently been shown to
activate microglia in vitro (Kim et al., 2005). Additional mediator candidates include
platelet-activating factor (PAF), a phospholipid that plays various roles in neuronal
function and whose receptor is expressed in microglial cells (Mori et al., 1996; Aihara
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et al., 2000) as well as neurotransmitters (e.g. glutamate) released by neurons which
may signal adjacent microglia via receptor-based interactions (Noda et al., 2000).
Finally, a recently identified chemokine, fractalkine, appears to function as an important
signaling molecule between neurons and microglia (Mizuno et al., 2003). The specific
receptor, CX3CR1, is found primarily on microglia suggesting an important signaling
role for this molecule (Nishiyori et al., 1998). Similarly, the cysteine-cysteine
chemokine receptor 5, which may be stimulated by a number of biologically active
molecules, has recently been shown to play a role in microglial activation and motility
following focal stab wounding (Carbonell et al., 2005).
Taken together, these studies strongly suggest neuronal injury-mediated
microglial signaling within the context of normal brain function and during the period
immediately following traumatic insult. The list of microglial activators is sure to grow
as our understanding of the neuronal response to injury continues to evolve.
Additionally, associated glial responses from cells such as astrocytes are also involved
in microglial activation via the release of various stimulatory molecules and thus
contribute to neuroinflammatory responses (Aldskogius and Kozlova, 1998; Shih et al.,
2006). Along these lines, our ability to manipulate these signaling molecules
individually or in combination may offer an opportunity to intervene therapeutically
with the hope that regulation of neuroinflammatory responses may promote
neuroprotective strategies while limiting unintended neuropathological consequences.
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CYTOKINES FOLLOWING TRAUMATIC BRAIN INJURY
Continued studies are needed to discern the chemotactic factors involved in
leukocyte recruitment to DBI loci although cytokines and chemokines generated by
glial cells have been implicated in this process (Bajetto et al., 2002; Babcock et al.,
2003). Cytokines are usually released within minutes after an appropriate stimulus
because they are stored intracellularly as precursor molecules and eventually modified
into active molecules. Following activation, microglia may secrete pro-inflammatory
cytokines, most notably interleukin 1 (IL-1) (Gentleman et al., 2004). IL-1 is
synthesized by microglia following experimental brain injury and can be found in
microglia close to APP immunoreactive cells and neurites in head-injured patients
(Fagan and Gage, 1990; Taupin et al., 1993; Griffin et al., 1994). Other cytokines
elevated in the brain following traumatic injury are IL-6 and tumor necrosis factor alpha
(TNF-a) (Goodman et al., 1990; McClain et al., 1991; Shohami et al., 1999). Both IL-1
and TNF-a are capable of altering vascular permeability and could facilitate
macrophage entry into parenchymal areas from which microglia secrete these molecules
thus facilitating macrophage interactions with injured neurons (Beynon et al., 1993;
Burke-Gaffney and Keenan, 1993). However, Soares and colleagues suggest that
inflammatory leukocyte recruitment and diffuse neuronal degeneration are separate
pathological processes resulting from TBI. Following lateral FPI, neuronal degeneration
took place within deep diencephalic structures in the absence of IgG extravasation and
neutrophil infiltration (Soares et al., 1995). Taken together, these data illustrate a
discrepancy as to the importance of leukocyte recruitment in response to neuronal
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degeneration following trauma and highlight the importance of continued research into
cytokine / chemokine mechanisms of action.
Similar discrepancies exists concerning activation of intracellular adhesion
molecule 1 (ICAM-I), which is pivotal in mediating the extravasation of leukocytes
across cerebral vessels, as well as with chemokines associated with leukocyte
recruitment within the context of TBI (Morganti-Kossmann et al., 2002). ICAM-1
expression is increased in the cerebral vessels of rats with diffuse axonal injury, despite
the absence of neutrophils in the brain parenchyma. Similarly, monocyte chemotactive
protein 1 (MCP-1; acting on macrophages) but not macrophage inflammatory protein 2
(MIP-2; acting on neutrophils) was elevated in these animals further supporting these
findings (Rancan et al., 2001). However, both chemokines were elevated following
focal brain injury, corroborating the finding of neutrophil and macrophage
accumulation within cortical contusions (Otto et al., 2001). These data highlight
heterogeneous inflammatory responses within the contexts of focal and diffuse TBI and
illustrate the complexity of molecular interactions taking place during the secondary
phases of injury. The roles of cytokines and chemotactic factors in leukocyte
recruitment as well as in glial activation following DBI remain the focus of ongoing
studies.

NEUROINFLAMMA TORY CONCLUSIONS
While dissimilar from DBI pathology which leads to secondary axotomy,
studies of inflammatory responses to primary axotomy provide a starting point to
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examine immune cell reactivity to traumatic injury. Facial nerve axotomy via
transection leads to microglial activation within hours after injury with microglia
remaining in the area for at least two weeks. Transection leads to perineuronal
ensheathment of neurons by microglia which accomplishes two neuroprotective actions:
removal of excitatory input through displacement of afferent synapses known as
synaptic stripping (Blinzinger and Kreutzberg, 1968) and close physical proximity of
axotomized neurons to microglial cells which may facilitate targeted delivery of growth
and/or neurotrophic factors promoting regeneration (Streit, 2002). Microglia are thought
to be essential components of the neuronal regenerative response, a response which is
blunted within the CNS by a variety of factors, based on the fact that transectionmediated axotomy of rubrospinal tract neurons in the cervical spinal cord, that does not
result in regeneration, elicits only minimal microglial activation (Barron et al., 1990;
Tseng et al., 1996). Given the diffuse nature of TAI which leads to comparatively less
pathology than is seen following focal brain injury and/or axonal transection paradigms,
both of which elicit cell death, lack of specific DBI-mediated microglia - axonal
interactions during the acute post-injury phases appears reasonable. It is not surprising
that DBI-mediated perisomatic TAI, which demonstrates rapid axolemmal closure as
discussed in Chapter 2, does not elicit robust microglial / macrophage activation
targeting the site of injury. On the other hand, our data do indicate macrophage
localization to somata of injured neurons with evidence of bouton disruption. However,
the lack of cell death does not allow for a massive inflammatory response given that the
primary trigger for such a response (i.e. cell death) is absent.
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Ultimately, the balance between neuroprotection and neuropathology within the
context of TBI-induced neuroinflammation is delicate. Inflammatory cell recruitment,
activation, and repair mechanisms are important components to preserve remaining
neuronal structure and function and to protect the brain from potentially more serious
consequences. However, the neuroprotective response must be tightly regulated to
prevent unintended and deleterious consequences resulting in damage to adjacent
uninjured tissue. Appropriate responses to injury must be tapered by mechanisms of
downregulation following completion of repair processes. These mechanisms may
include migration of inflammatory cells away from injury sites and/or immune cell
apoptosis (Vela et al., 2002). Otherwise, an unregulated inflammatory response will
ultimately promote increased neuronal injury that will stimulate continued and/or de
novo inflammatory responses creating vicious cycles of neuronal injury followed by
further neuroinflammation leading to even greater neuronal injury. Unfortunately, our
current understanding of these regulatory mechanisms is incomplete and merits
continued investigation. Through future studies, our comprehension of the basic science
mechanisms behind neuroinflammation will lead to therapeutic interventions targeting
various steps in the inflammatory cascade, ultimately creating a process that may be
manipulated and hence regulated to enhance neuroprotection while limiting unwanted
neuropathological consequences.

FUTURE STUDIES
While this dissertation offers new insights into DBI and its associated
pathologies, much work still remains to fully comprehend this pathological condition.
The anatomical reproducibility of perisomatic TAI within the mediodorsal neocortex,
hippocampal dentate gyrus, and dorsolateral thalamus using the midlinelcentral FPI
model of moderate severity combined with an established timeline for perisomatic TAI
and subsequent secondary axotomy within this cytoarchitectural region provides several
possibilities for future investigations. First, regional specificity of perisomatic TAI
allows for thorough examination of the consequent deafferentation associated with
axotomy, Wallerian change, and synaptic disruption. By focusing on the anatomical
endpoints to which injured axons project, the impact of DBI-mediated secondary
axotomy on downstream synaptic terminals may be examined. Through collaborative
efforts with investigators at other university, we are beginning to examine regional
neuronal injury responses to diffuse TBI via Western blot analyses of antibodies
targeting pre (e.g. synaptophysin, synaptotagmin) and post-synaptic (e.g. PSD-95, PSD93) elements as well as axonal constituents (e.g. myelin breakdown products).
Following characterization of these injured loci, the anatomical areas to which these
injured axons project will then be examined by Western blot and LM I EM
immunohistochemistry to determine the mechanisms and consequences of DBImediated deafferentation. Although this effort is in its early stages, initial results
indicate a coordinated temporal response to diffuse TAI with elevations in myelin

breakdown products followed by synaptic breakdown products (unpublished
observations).
In addition to the synaptic fate associated with secondary axotomy,
characterization of the axonal disconnection site also requires continued investigation.
As reported in Chapter 2, sites of perisomatic axotomy were impermeable to pre-injury
administered 10 kDa dextran. While this finding was unexpected and suggested either
axolemmal sealing prior to disconnection or ultra-rapid axolemmal closure following
axotomy, these hypotheses require additional testing to provide more substantive
evidence supporting mechanisms of membrane resealing I repair. Use of a smaller
molecular weight dextran molecule may provide insight into potential size disruptions
within the axolemma. Perhaps disruption sizes are such that they exclude the 10 kDa
dextran but may be permeable to smaller molecular weight species. Similarly, more
refined EM studies may provide insight into membranous cytoskeleton structural
dynamics at the point of disconnection. Understanding neuronal membrane disruption
and resealing is important to designing rational therapeutic strategies aimed at either
repairing the membrane itself or targeting ongoing pathologies via intra-neuronal
delivery of pharmacological agents during the post-traumatic period.
From the standpoint of DBI-mediated neuroinflammatory responses, initial
characterization was offered in Chapter 3 although these findings are only preliminary
descriptions of this complex biological process. The midlinelcentral FPI model elicits
diffuse TAI within specific anatomical loci that are uncomplicated by elements of focal
injury. This offers a unique opportunity to model DBI without underlying focal injury
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components that may confound inflammatory cell analyses. One question that arose
during evaluation of macrophage immunoreactivity is from where do these cells
originate? To date, the precise origin(s) for brain macrophages following trauma
remains elusive although the nature of the injury may dictate the relative contributions
of endogenous and exogenous cells. Macrophages may differentiate from endogenous
microglia following activation, may be recruited from the peripheral blood as
monocytes and then differentiate upon arrival at the injury site, or both of these
mechanisms may be at work simultaneously. Two experimental strategies could be used
to study this question. First, bone marrow chimeric animals may be utilized based on
their unique cellular properties. While microglia enter the brain during embryonic
development and self-renew, monocytes originate from bone marrow throughout life.
Monocytes derived from chimeric bone marrow will have unique protein characteristics
distinguishing them from endogenous brain cell populations. Following DBI and
macrophage differentiation, antibodies targeting the unique chimeric phenotype could
provide evidence of either immunopositive bone marrow-derived monocyte entry,
immunonegative microglial differentiation, or a combination of exogenous and
endogenous cells. If both macrophage lineages are present, these studies will still
provide valuable information as to the relative contributions made by each lineage as
well as lineage-dependent localization following injury. In a related approach, preinjury labeling of circulating blood monocytes with a fluorescent marker could also
allow for brain identification and localization of these cells following injury.
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In sum, this dissertation provides further characterization of DBI-mediated TAI
pathology and neuroinflammatory responses. TAI within the perisomatic domain results
in ultra-rapid secondary axotomy with consequent Wallerian change and is highlighted
by apparent axolemmal impermeability. The neuroinflammatory response
accompanying this pathology is characterized by early, yet initially uncoordinated, and
persistent activated microglial / macrophage reactivity which fails to target sites of
axonal injury during the acute post-injury stages and does not reveal evidence of
immune cell clustering / nodule formation. However, macrophages approximated
somata of injured neurons but did not reveal somatic engulfment or phagocytic activity.
These immunological findings are distinct from those observed following focal brain
injury and further illustrate the heterogeneous responses to DBI. Taken together, these
studies provide the impetus for future examinations of the mechanisms of DBI-related
pathologies, namely DAI pathogenesis and secondary neuroinflammatory responses.
From a clinical standpoint, the overall number of TBI cases has fallen in recent
years; however, one must be careful when interpreting this statistic. If TBI incidents are
stratified by their level of severity, severe cases have decreased while mild to moderate
cases have remain constant or increased. Improvements in highway safety, vehicle
construction, and personal protective equipment have greatly contributed to the decline
in severe incidents. However, individuals suffering mild to moderate injury often do not
seek medical treatment due to the relative paucity of symptoms only to later present
with physical andlor cognitive issues requiring medical attention. In that mild to
moderate TBI often includes significant DBI, it is hoped that this work will further
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stimulate research into the mechanisms of DBI pathology with the goals of ameliorating
or eliminating DAI via targeted therapeutic interventions and manipulating
neuroinflammation to maximize neuroprotective effects while minimizing
neuropathological consequences.
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